<SEC-DOCUMENT>0001493152-22-029722.txt : 20221027
<SEC-HEADER>0001493152-22-029722.hdr.sgml : 20221027
<ACCEPTANCE-DATETIME>20221027162258
ACCESSION NUMBER:		0001493152-22-029722
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20221024
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Cost Associated with Exit or Disposal Activities
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20221027
DATE AS OF CHANGE:		20221027

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			STREAMLINE HEALTH SOLUTIONS INC.
		CENTRAL INDEX KEY:			0001008586
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373]
		IRS NUMBER:				311455414
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0131

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-28132
		FILM NUMBER:		221337625

	BUSINESS ADDRESS:	
		STREET 1:		2400 OLD MILTON PARKWAY
		STREET 2:		BOX 1353
		CITY:			ALPHARETTA
		STATE:			GA
		ZIP:			30009
		BUSINESS PHONE:		888-997-8732

	MAIL ADDRESS:	
		STREET 1:		2400 OLD MILTON PARKWAY
		STREET 2:		BOX 1353
		CITY:			ALPHARETTA
		STATE:			GA
		ZIP:			30009

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	STREEAMLINE HEALTH SOLUTIONS INC.
		DATE OF NAME CHANGE:	20060809

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LANVISION SYSTEMS INC
		DATE OF NAME CHANGE:	19960220
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:us-gaap-supplement="http://fasb.org/us-gaap-sup/2022q3" xmlns:srt-supplement="http://fasb.org/srt-sup/2022q3" xmlns:us-roles="http://fasb.org/us-roles/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:STRM="http://streamlinehealth.net/20221024">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02B_US%2DGAAP%2D2022 -->
<!-- Field: Set; Name: xdx; ID: xdx_037_STRM_streamlinehealth.net_20221024 -->
<!-- Field: Set; Name: xdx; ID: xdx_04D_20221024_20221024 -->
<!-- Field: Set; Name: xdx; ID: xdx_05D_edei%2D%2DEntityCentralIndexKey_0001008586 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-10-24to2022-10-24" name="dei:EntityCentralIndexKey">0001008586</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-10-24to2022-10-24" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="strm-20221024.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-10-24to2022-10-24">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001008586</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-10-24</xbrli:startDate>
        <xbrli:endDate>2022-10-24</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1.5pt solid; text-align: center; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_90B_edei--DocumentType_c20221024__20221024_zrDBn9EowWT3"><ix:nonNumeric contextRef="From2022-10-24to2022-10-24" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pursuant
to Section 13 or 15(d) of The</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities
Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Report (Date of earliest event reported): <b><span id="xdx_90B_edei--DocumentPeriodEndDate_c20221024__20221024_zwReUpVmL7u9"><ix:nonNumeric contextRef="From2022-10-24to2022-10-24" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">October 24, 2022</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_901_edei--EntityRegistrantName_c20221024__20221024_ze7dkudI4BAb"><ix:nonNumeric contextRef="From2022-10-24to2022-10-24" name="dei:EntityRegistrantName">Streamline
Health Solutions, Inc.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_907_edei--EntityIncorporationStateCountryCode_c20221024__20221024_zAq49lupT68k"><ix:nonNumeric contextRef="From2022-10-24to2022-10-24" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90D_edei--EntityFileNumber_c20221024__20221024_z6zNs4qmoueh"><ix:nonNumeric contextRef="From2022-10-24to2022-10-24" name="dei:EntityFileNumber">0-28132</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_903_edei--EntityTaxIdentificationNumber_c20221024__20221024_zL1Izacu81H8"><ix:nonNumeric contextRef="From2022-10-24to2022-10-24" name="dei:EntityTaxIdentificationNumber">31-1455414</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State or other jurisdiction</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of incorporation)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File Number)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S. Employer</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification No.)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_903_edei--EntityAddressAddressLine1_c20221024__20221024_zJdknGLHRqLj"><ix:nonNumeric contextRef="From2022-10-24to2022-10-24" name="dei:EntityAddressAddressLine1">2400
Old Milton Pkwy.</ix:nonNumeric></span>, <span id="xdx_904_edei--EntityAddressAddressLine2_c20221024__20221024_zjM6vqDAs5y4"><ix:nonNumeric contextRef="From2022-10-24to2022-10-24" name="dei:EntityAddressAddressLine2">Box 1353</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90A_edei--EntityAddressCityOrTown_c20221024__20221024_zjIIxaSxDQ89"><ix:nonNumeric contextRef="From2022-10-24to2022-10-24" name="dei:EntityAddressCityOrTown">Alpharetta</ix:nonNumeric></span>,
<span id="xdx_905_edei--EntityAddressStateOrProvince_c20221024__20221024_zwi8TUPlUzOd"><ix:nonNumeric contextRef="From2022-10-24to2022-10-24" name="dei:EntityAddressStateOrProvince">GA</ix:nonNumeric></span> <span id="xdx_90C_edei--EntityAddressPostalZipCode_c20221024__20221024_zohmfQOtcFc3"><ix:nonNumeric contextRef="From2022-10-24to2022-10-24" name="dei:EntityAddressPostalZipCode">30009</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
of principal executive offices) (Zip Code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&#8217;s
telephone number, including area code: <b><span id="xdx_900_edei--CityAreaCode_c20221024__20221024_z2sHBRJjAIXd"><ix:nonNumeric contextRef="From2022-10-24to2022-10-24" name="dei:CityAreaCode">(888)</ix:nonNumeric></span> <span id="xdx_90B_edei--LocalPhoneNumber_c20221024__20221024_zruZu0eVVqwg"><ix:nonNumeric contextRef="From2022-10-24to2022-10-24" name="dei:LocalPhoneNumber">997-8732</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_edei--WrittenCommunications_c20221024__20221024_zyKbxDgvmINh"><ix:nonNumeric contextRef="From2022-10-24to2022-10-24" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span><span id="xdx_906_edei--SolicitingMaterial_c20221024__20221024_z7EicU7toXHl"><ix:nonNumeric contextRef="From2022-10-24to2022-10-24" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span><span id="xdx_909_edei--PreCommencementTenderOffer_c20221024__20221024_z896b1cQUr19"><ix:nonNumeric contextRef="From2022-10-24to2022-10-24" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90E_edei--PreCommencementIssuerTenderOffer_c20221024__20221024_zHXpBumaCD32"><ix:nonNumeric contextRef="From2022-10-24to2022-10-24" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 34%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of each class</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 18%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    Symbol</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 44%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of each exchange on which registered</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_909_edei--Security12bTitle_c20221024__20221024_zul4udrk8n3d"><ix:nonNumeric contextRef="From2022-10-24to2022-10-24" name="dei:Security12bTitle">Common
    Stock, $0.01 par value</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90F_edei--TradingSymbol_c20221024__20221024_zRa3hB9CJ2Di"><ix:nonNumeric contextRef="From2022-10-24to2022-10-24" name="dei:TradingSymbol">STRM</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span><span id="xdx_905_edei--SecurityExchangeName_c20221024__20221024_zPjVEN0JkfI4"><ix:nonNumeric contextRef="From2022-10-24to2022-10-24" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span>
    Capital Market</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 4in; text-align: right; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_90E_edei--EntityEmergingGrowthCompany_c20221024__20221024_z9TUudU1Eb0h"><ix:nonNumeric contextRef="From2022-10-24to2022-10-24" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
    1.01</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Entry
    into a Material Definitive Agreement.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 24, 2022, Streamline Health Solutions, Inc. (the &#8220;Company&#8221;) entered into purchase agreements (collectively, the &#8220;Purchase
Agreements&#8221;) with purchasers named therein (the &#8220;Purchasers&#8221;), pursuant to which the Company agreed to issue and sell
in a registered direct offering an aggregate of 6,299,989 shares of common stock, par value $0.01 per share (the &#8220;Common Stock&#8221;),
at a purchase price of $1.32 per share (the &#8220;Offering&#8221;). The gross proceeds to the Company from the Offering are expected
to be approximately $8.3 million after deducting estimated offering expenses payable by the Company. The Company intends to use the proceeds
of the Offering for general corporate purposes. The Offering closed on October 26, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares of Common Stock were offered pursuant to a prospectus supplement dated October 24, 2022, and a prospectus dated September 13,
2022, which is part of a registration statement on Form S-3 (Registration No. 333-267187) that was declared effective by the Securities
and Exchange Commission (the &#8220;SEC&#8221;) on September 13, 2022. A copy of the legal opinion of Troutman Pepper Hamilton Sanders
LLP, relating to the validity of the shares issued in the Offering, is filed as Exhibit 5.1 to this Current Report on Form 8-K and is
filed with reference to, and is hereby incorporated by reference into, the Registration Statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares of common stock were offered directly to the Purchasers without a placement agent, underwriter, broker or dealer. Certain directors
and officers of the Company and affiliated entities contributed approximately $2.5 million to the Offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Purchase Agreements contain customary representations, warranties, and agreements by the Company, and customary indemnification and other
obligations of the Company and the Purchasers. The foregoing summary of the Purchase Agreements is qualified in its entirety by the full
text of the Purchase Agreements, the form of which is filed herewith as Exhibit 10.1 and incorporated herein by reference. It is not
intended to provide any other factual information about the Company. The representations, warranties and covenants contained in the Purchase
Agreements were made only for purposes of the Purchase Agreements as of specific dates, were solely for the benefit of the parties to
the Purchase Agreements and may be subject to limitations agreed upon by the contracting parties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 25, 2022, the Company issued a press release announcing the Offering, a copy of which is attached hereto as Exhibit 99.1 and
incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
    2.05</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Costs
    Associated with Exit or Disposal Activities.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 26, 2022, the Board of Directors (the &#8220;Board&#8221;) of the Company approved a plan to strategically align the Company&#8217;s
operations and to simplify the Company&#8217;s business in order to drive sustainable growth and improved profitability and cash flow.
The plan prioritizes near term revenue generators and implements cost reduction measures intended to improve the Company&#8217;s operations
and client services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
part of this strategic alignment, the Company reported temporary base salary reductions of 0% to 30% for the executive team from November
2022 through October 2023, with a reduction of 30% for Wyche T. &#8220;Tee&#8221; Green, III, and Jawad Shaikh, and 10% for each of Thomas
J. Gibson, Wendy Lucio and Amy Sebero. The Company will enter into amendments with Mr. Green, Mr. Gibson and Ms. Lucio to reflect
these changes in their existing employment agreements. The alignment plan also includes a reduction in workforce resulting in the
termination of approximately 10 employees, or approximately 7% of the Company&#8217;s employee workforce effective as of October 27,
2022. The Company also eliminated four independent contractors from its cost structure. As a result of the alignment plan, the Company
anticipates that it will incur approximately $300,000 in one-time severance and other employee termination-related costs. The Company
is not currently aware of any other significant charges it will incur as a result of the alignment plan. The Company expects that these
charges will be recorded in its fiscal third quarter of its fiscal year 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the strategic alignment, the Compensation Committee of the Board, approved new grants of restricted stock awards (RSAs)
for its executive officers in the aggregate of 400,000 shares. Included in these grants are grants to Wyche T. &#8220;Tee&#8221; Green,
III of 50,000 RSAs, Ben Stilwill of 100,000 RSAs, Wendy Lucio of 50,000 RSAs, and Thomas J Gibson of 50,000 RSAs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
    5.02</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Departure
    of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the strategic alignment, the Board appointed Ben Stilwill as President of the Company, effective October 26, 2022. Mr.
Stilwill, 33, joined the Company in 2013 and previously held roles in Finance, Corporate Development, IT Infrastructure and Sales. Mr.
Stilwill served as Senior Vice President, Customer Success from March 2020 until February 2022, when he was named President &amp; CEO
of eValuator Solutions. Mr. Stilwill received his bachelor&#8217;s degree from DePauw University and his Executive MBA from Villanova
University. The parties intend to enter into an amendment to Mr. Stilwill&#8217;s employment agreement (the &#8220;Employment Agreement&#8221;)
to reflect these changes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
term of Mr. Stilwill&#8217;s existing Employment Agreement is one (1) year, commencing February 15, 2022, and renews automatically for
subsequent twelve (12)-month periods, unless Mr. Stilwill or the Company provides written notice at least sixty (60) calendar days prior
to the end of the applicable year to the other of his or its intention to not renew the employment. Mr. Stilwill receives an annual base
salary of $280,000 and is eligible for an annual incentive bonus (at target equal to fifty percent (50%) of his annual base salary),
based on individual and Company performance. Mr. Stilwill is also eligible to receive the standard employee benefits made available by
the Company to its employees generally. Mr. Stilwill was also granted a restricted stock award of 100,000 shares following the execution
of the Employment Agreement. The shares of restricted stock vest in three (3) equal annual installments, subject to the continued employment
of Mr. Stilwill on each vesting date. The Employment Agreement contains customary confidentiality provisions and non-competition covenants.
If the Employment Agreement is terminated by the Company for reasons other than death, Continued Disability, or Good Cause, or if Mr.
Stilwill terminates employment for Good Reason, Mr. Stilwill will generally be entitled to receive: (1) accrued but unpaid salary through
the termination date through his termination date; (2) reimbursement of expenses incurred prior to his termination date; and (3) any
vested benefits earned by Mr. Stilwill prior to his termination date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information contained in Item 2.05 of this Current Report on Form 8-K regarding the Company&#8217;s strategic alignment is incorporated
herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
    7.01</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Regulation
    FD Disclosure.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Offering, the Company disclosed to the Purchasers anticipated &#8220;SaaS Bookings ACV&#8221; of $17.0 million at
the end of fiscal year 2022 and $30.0 million at the end of fiscal year 2023. The Company expects to generate positive cash from operations
(defined as adjusted EBITDA less capitalized software development) in the third quarter of fiscal 2023. Lastly, the Company expects it
can generate 30% EBITDA margins from its revenue mix, with increased SaaS recognized revenue, within the next 12 to 24 months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 27, 2022, the Company issued a press release announcing the strategic alignment, Mr. Stilwill&#8217;s appointment, and the closing
of the Offering. The full text of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and shall not be
deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the
liabilities of that Section.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Safe
Harbor Statement under the Private Securities Litigation Reform Act of 1995</b>:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Current Report on Form 8-K may contain certain &#8220;forward-looking statements&#8221; within the meaning of the Private Securities
Litigation Reform Act of 1995. These include statements regarding, but not limited to, the anticipated closing of the Offering and the
Company&#8217;s expected uses of the proceeds from the Offering, the estimated charges and savings associated with the Company&#8217;s
realignment plan. Forward-looking statements can be identified by the use of words such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;plan,&#8221;
&#8220;should,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;estimate,&#8221; &#8220;continue&#8221; or comparable terminology.
Forward-looking statements involve risks and uncertainties that could cause actual results or developments to differ materially from
those indicated due to a number of factors affecting Streamline&#8217;s operations, markets, products and services. The Company identifies
the principal risks and uncertainties that impact its performance in its public reports filed with the SEC, including the &#8220;Risk
Factors&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition&#8221; sections of Streamline&#8217;s most
recent Annual Report on Form 10-K, as may be supplemented or amended by the Company&#8217;s subsequent Quarterly Reports on Form 10-Q.
Forward-looking statements speak only as of the date on which they are made and the Company undertakes no obligation to publicly release
the results of any revision to such forward-looking statements, which may be made to reflect events or circumstances after the date hereof
or to reflect the occurrence of unanticipated events, except as required by applicable law.</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
    9.01</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial
    Statements and Exhibits.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(d)
Exhibits.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.75in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EXHIBIT</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NUMBER</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DESCRIPTION</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex5-1.htm">Opinion of Troutman Pepper Hamilton Sanders LLP</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-1.htm">Form of Common Stock Purchase Agreement dated as of October 24, 2022, by and among Streamline Health Solutions, Inc. and the purchasers thereto.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex99-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press release, dated October 25, 2022, regarding the Offering</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex99-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press release, dated October 27, 2022, regarding strategic alignment and the closing of the Offering</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>STREAMLINE
    HEALTH SOLUTIONS, INC.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 47%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    October 27, 2022</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Thomas J. Gibson</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thomas
    J. Gibson</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 5; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjUEKwjAQRU/QOwxZiyYBXXRpURGrSBFxG+xUgm2mTNKqR/KWxhZxGBiG/9//QkzEhta2RobLssjhhE1bm4BQYIWM7orRkW13KcRb4M36wMaF4f2BGUUGIzOfqoWJwmDtrccyBSVnejHTGqRKlYTjXiRfPSNX2RJdsKYG40o4MrVsMRh+jQkn8yRHzWuoOiN7Sy7GTeUov0FLpeFAvXkQ3z3keSaSyTCJ2DB17bem84EaWNXYxC4/ov9NPhQESUI= -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>ex5-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
5.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Troutman
                                            Pepper Hamilton Sanders LLP</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">600
    Peachtree Street NE, Suite 3000</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Atlanta,
    GA 30308-2216</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">troutman.com</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"></P></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif"><IMG SRC="ex5-1_001.jpg" ALT=""></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="font-family: Times New Roman, Times, Serif; margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="font: 1pt Times New Roman, Times, Serif; border-top: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D
                                            404.885.3000</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F
    404.885.3900</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
26, 2022</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Streamline
Health Solutions, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2400
Old Milton Pkwy., Box 1353</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alpharetta,
GA 30009</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RE:</B></FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registered Direct Offering</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have acted as counsel to Streamline Health Solutions, Inc., a Delaware corporation (the &ldquo;Company&rdquo;), in connection with the
issuance and sale of 6,299,989 shares (the &ldquo;Shares&rdquo;) of the Company&rsquo;s common stock, $0.01 par value per share (the
&ldquo;Common Stock&rdquo;), pursuant to common stock purchase agreements, each dated October 24, 2022, by and between the Company and
each investor signatory thereto (collectively, the &ldquo;Purchase Agreements&rdquo;). The Shares will be issued pursuant to the Company&rsquo;s
Registration Statement on Form S-3 (No. 333-267187) as filed by the Company with the Securities and Exchange Commission (the &ldquo;Registration
Statement&rdquo;), pursuant to the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;) and the related prospectus dated
September 13, 2022, and prospectus supplement dated October 24, 2022 (collectively, the &ldquo;Prospectus&rdquo;). We have examined the
Registration Statement, the Prospectus, the Purchase Agreements and originals or copies of such corporate records, agreements and instruments
of the Company, statements and certificates of public officials and officers of the Company, and such other documents, records and instruments
as we have deemed necessary or appropriate as a basis for us to render the opinions hereinafter expressed. In our examination of the
foregoing, we have assumed the genuineness of all signatures, the legal competence and capacity of natural persons, the authenticity
of documents submitted to us as originals and the conformity with authentic original documents of all documents submitted to us as copies.
We have relied without independent investigation as to matters of fact upon statements of governmental officials and upon representations
made in or pursuant to the certificates and statements of appropriate representatives of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not purport to express an opinion on any laws other than the General Corporation Law of the State of Delaware. The opinions set forth
herein are made as of the date hereof and are subject to, and may be limited by, future changes in the factual matters set forth herein,
and we undertake no duty to advise you of the same. The opinions expressed herein are based upon the law in effect (and published or
otherwise generally available) on the date hereof, and we assume no obligation to revise or supplement these opinions should such law
be changed by legislative action, judicial decision or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
upon the foregoing and in reliance thereon, and subject to the assumptions, comments, qualifications, limitations and exceptions set
forth herein, we are of the opinion that the Shares have been duly authorized for issuance, and when issued, delivered and paid for in
accordance with the Purchase Agreements, the Shares will be validly issued, fully paid and non-assessable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not render any opinions except as expressly set forth above. We hereby consent to the filing of this opinion as Exhibit 5.1 to the
Company&rsquo;s Current Report on Form 8-K dated October 27, 2022, incorporated by reference into the Registration Statement and to the
use of our name under the caption &ldquo;Legal Matters&rdquo; in the Prospectus. In giving this consent, we do not admit that we are
within the category of persons whose consent is required by Section 7 of the Securities Act or the rules and regulations promulgated
thereunder by the Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify; width: 50%"></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly yours,</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">/s/ Troutman Pepper Hamilton Sanders LLP</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Troutman Pepper Hamilton
  Sanders LLP</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 207pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 207pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 207pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>ex10-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font-family: Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font-family: Times New Roman, Times, Serif; text-align: right; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Exhibit 10.1</B></FONT></P>

<P STYLE="font-family: Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>COMMON
STOCK PURCHASE AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">This
Common Stock Purchase Agreement (this &ldquo;<B>Agreement</B>&rdquo;) is made as of [&#9679;], 2022, by and between [&#9679;] (the &ldquo;<B>Purchaser</B>&rdquo;),
and Streamline Health Solutions, Inc., a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><U>RECITALS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>A.
</B>Subject to the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities
Act of 1933, as amended (the &ldquo;<B>Securities Act</B>&rdquo;), the Company desires to issue and sell to the Purchaser, and the Purchaser
desires to purchase from the Company, securities of the Company as more fully described in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>B.
</B>This Agreement is part of a series of Common Stock Purchase Agreements (each other Common Stock Purchase Agreement, an &ldquo;<B>Other
Purchase Agreement</B>&rdquo;), each executed concurrently but as independent transactions, pursuant to which the Company has agreed
to sell and issue shares of its common stock to separate purchasers (each other purchaser, an &ldquo;<B>Other Purchaser</B>&rdquo;),
in each case at the same price per share as contemplated by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><U>TERMS
AND CONDITIONS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
consideration of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy
of which are hereby acknowledged, the Company and the Purchaser agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>ARTICLE
I</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>DEFINITIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>1.1
Definitions</B>. In addition to the terms defined elsewhere in this Agreement, the following terms have the meanings set forth in this
<U>Section 1.1</U>:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B>Affiliate</B>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B>Base
Prospectus</B>&rdquo; means the prospectus, dated September 13, 2022, contained in the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B>Closing</B>&rdquo;
means the closing of the purchase and sale of the Shares pursuant to <U>Section 2.2</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B>Closing
Date</B>&rdquo; means the Trading Day on which all conditions precedent to (i) the Purchaser&rsquo;s obligation to pay the Subscription
Amount and (ii) the Company&rsquo;s obligations to deliver the Shares, in each case, have been satisfied or waived, but in no event later
than the second Trading Day following the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B>Commission</B>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B>Common
Stock</B>&rdquo; means the common stock of the Company, par value $0.01 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B>Disclosure
Package</B>&rdquo; means, collectively, the Prospectus, together with the documents incorporated by reference therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B>Exchange
Act</B>&rdquo; means the Securities Exchange Act of 1934, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B>Prospectus</B>&rdquo;
means the Prospectus Supplement, together with the Base Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B>Prospectus
Supplement</B>&rdquo; means the supplement to the Base Prospectus complying with Rule 424(b) of the Securities Act that is filed with
the Commission and delivered by the Company to the Purchaser at the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B>Registration
Statement</B>&rdquo; means the effective registration statement with Commission File No. 333-267187 that registers the sale of the Shares
to the Purchaser, as such Registration Statement may be amended and supplemented from time to time (including pursuant to Rule 462(b)
of the Securities Act).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B>Securities
Act</B>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B>Shares</B>&rdquo;
means [&#9679;] shares of Common Stock issued or issuable to the Purchaser pursuant to the terms and conditions of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B>Short
Sales</B>&rdquo; means, all &ldquo;short sales&rdquo; as defined in Rule 200 promulgated under Regulation SHO under the Exchange Act,
whether or not against the box, and forward sale contracts, options, puts, calls, short sales, &ldquo;put equivalent positions&rdquo;
(as defined in Rule 16a-1(h) under the Exchange Act) and similar arrangements, and sales and other transactions through non-U.S. broker
dealers or foreign regulated brokers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B>Subscription
Amount</B>&rdquo; means $[&#9679;], the aggregate amount to be paid for the Shares purchased hereunder in United States dollars and in
immediately available funds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B>Trading
Day</B>&rdquo; means a day on which the Trading Market is open for trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B>Trading
Market</B>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, The Nasdaq Capital Market, The Nasdaq Global Market, The Nasdaq Global Select Market, the New York Stock
Exchange (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B>Transfer
Agent</B>&rdquo; means Computershare Inc., and any successor transfer agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>ARTICLE
II</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>PURCHASE
AND SALE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>2.1
</B>&nbsp;<B>Closing</B>. Upon the terms and subject to the conditions set forth herein, the Company has authorized the sale and issuance
to the Purchaser, and the Purchaser agrees to purchase from the Company, the Shares, for a purchase price of $[&#9679;] per Share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)
The offering and sale of the Shares (the &ldquo;<B>Offering</B>&rdquo;) is being made pursuant to (i) the Registration Statement filed
by the Company with the Commission, including the Base Prospectus; (ii) if applicable, certain &ldquo;free writing prospectuses&rdquo;
(as that term is defined in Rule 405 under the Securities Act) (&ldquo;<B>Free Writing Prospectus</B>&rdquo;) that have been or will
be filed, if required, with the Commission and delivered to the Purchaser on or before the date hereof, containing certain supplemental
information regarding the terms of the Offering and the Company; and (iii) the Prospectus Supplement containing certain supplemental
information regarding the Shares and the terms of the Offering and information that may be material to the Company and its securities
that was delivered to the Purchaser and will be filed with the Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)
There is no placement agent or underwriter for this Offering. The Shares are being issued directly by the Company to the Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>2.2
Closing and Delivery of the Shares and Funds</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)
The Closing shall take place at the offices of Troutman Pepper Hamilton Sanders LLP, 600 Peachtree St NE, Suite 3000, Atlanta, Georgia
30308, or such other location as the parties shall mutually agree upon, on the Closing Date. At or prior to the Closing, (i) the Purchaser
shall deliver to the Company, (x) this Agreement duly executed by the Purchaser and, (y) via wire transfer, immediately available funds
equal to the Subscription Amount, and (ii) the Company shall deliver (x) this Agreement duly executed by the Company (y) the Prospectus
Supplement to the Purchaser (which may be delivered in accordance with Rule 172 under the Securities Act) and (z) irrevocable instructions
to the Transfer Agent instructing the Transfer Agent to deliver, via The Depository Trust Company Deposit or Withdrawal at Custodian
system, the Shares registered in the name of the Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)
The Company&rsquo;s obligation to issue and sell the Shares to the Purchaser shall be subject to: (i) no stop order suspending the effectiveness
of the Registration Statement or any part thereof, or preventing or suspending the use of the Base Prospectus or the Prospectus or any
part thereof, shall have been issued and no proceedings for that purpose or pursuant to Section 8A under the Securities Act shall have
been initiated or threatened by the Commission; (ii) no objection shall have been raised by the Trading Market with respect to the consummation
of the transactions contemplated by this Agreement; (iii) the accuracy in all material respects (or, to the extent representations or
warranties are qualified by materiality, in all respects) on the Closing Date of the representations and warranties of the Purchaser
contained herein (unless as of a specific date therein in which case they shall be true and correct as of such date); and (iv) the delivery
by the Purchaser of the items set forth in <U>Section 2.2(a)</U> of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)
The Purchaser&rsquo;s obligation to purchase the Shares from the Company shall be subject to: (i) no stop order suspending the effectiveness
of the Registration Statement or any part thereof, or preventing or suspending the use of the Base Prospectus or the Prospectus or any
part thereof, shall have been issued and no proceedings for that purpose or pursuant to Section 8A under the Securities Act shall have
been initiated or threatened by the Commission; (ii) no objection shall have been raised by the Trading Market with respect to the consummation
of the transactions contemplated by this Agreement; (iii) there shall have been no Material Adverse Effect since the date hereof; (iv)
all obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;
(v) the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse
Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless
as of a specific date therein, which shall be true and correct as of such specified date); and (vi) the delivery by the Company of the
items set forth in <U>Section 2.2(a)</U> of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>ARTICLE
III</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>REPRESENTATIONS
AND WARRANTIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>3.1
Representations, Warranties and Covenants of the Company</B>. The Company acknowledges, represents and warrants to, and agrees with,
the Purchaser that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)
The Company has the requisite right, power and authority to enter into this Agreement, to authorize, issue and sell the Shares as contemplated
by this Agreement and to perform and to discharge its obligations hereunder; and this Agreement has been duly authorized, executed and
delivered by the Company, and constitutes the valid and binding obligation of the Company enforceable in accordance with its terms, except
as may be limited by bankruptcy, insolvency, reorganization or other similar laws relating to enforcement of creditors&rsquo; rights
generally and by general principles of equity. No approval of the Company&rsquo;s stockholders or any other corporate action on the part
of the Company is necessary to authorize the execution, delivery and performance of this Agreement by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)
The Shares have been duly authorized and the Shares, when issued and delivered against payment therefor as provided in this Agreement,
will be validly issued, fully paid and non-assessable and free of any preemptive or similar rights. The Registration Statement is effective
under the Securities Act and no stop order preventing or suspending the effectiveness of the Registration Statement or suspending or
preventing the use of the Prospectus has been issued by the Commission and no proceedings for that purpose have been instituted or, to
the knowledge of the Company, are threatened by the Commission. No objection has been raised by the Trading Market with respect to the
consummation of the transactions contemplated by this Agreement or any Other Purchase Agreement. The Company, if required by the rules
and regulations of the Commission, proposes to file the Prospectus with the Commission pursuant to Rule 424(b) in relation to the sale
of the Shares. There are a sufficient number of shares of Common Stock available for issuance under the Registration Statement to issue
the Shares and all of the other shares of Common Stock issuable pursuant to the Other Purchase Agreements pursuant to the Registration
Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)
The execution and delivery of this Agreement or any Other Purchase Agreement and the consummation of the transactions contemplated hereby
will not (i) result in a breach or violation of any of the terms and provisions of, or constitute a default under, any law, rule or regulation
to which the Company or any of its subsidiaries is subject, or by which any property or asset of the Company or any of its subsidiaries
is bound or affected, (ii) conflict with, result in any violation or breach of, or constitute a default (or an event that with notice
or lapse of time or both would become a default) under, or give to others any right of termination, amendment, acceleration or cancellation
(with or without notice, lapse of time or both) of, any agreement, lease, credit facility, debt, note, bond, mortgage, indenture or other
instrument or obligation or other understanding to which the Company or any of its subsidiaries is a party or by which any property or
asset of the Company or any of its subsidiaries is bound or affected, or (iii) result in a breach or violation of any of the terms and
provisions of, or constitute a default under, the Company&rsquo;s articles of incorporation or bylaws, except in the case of clauses
(i) and (ii) such breaches, violations, defaults, or conflicts which are not, and would not be, individually or in the aggregate, reasonably
likely to result in a material adverse effect upon the business, properties, operations, condition (financial or other) or results of
operations of the Company and its subsidiaries, taken as a whole, or in its ability to perform its obligations under this Agreement or
any Other Purchase Agreement (a &ldquo;<B>Material Adverse Effect</B>&rdquo;; <U>provided</U>, <U>however</U>, that changes in the trading
price of the Common Stock shall not, in and of themselves, constitute a Material Adverse Effect).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)
The Company has filed all reports, schedules, forms, statements and other documents required to be filed by the Company under the Securities
Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the two (2) years preceding the date hereof (or such
shorter period as the Company was required by law or regulation to file such material) (the foregoing materials, including the exhibits
thereto and documents incorporated by reference therein, being collectively referred to herein as the &ldquo;<B>SEC Reports</B>&rdquo;)
on a timely basis or has received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration
of any such extension. As of their respective dates, the SEC Reports complied in all material respects with the requirements of the Securities
Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or
omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of
the circumstances under which they were made, not misleading. The Company has never been an issuer subject to Rule 144(i) under the Securities
Act. The financial statements of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements
and the rules and regulations of the Commission with respect thereto as in effect at the time of filing. Such financial statements, as
of their respective dates, were prepared in accordance with United States generally accepted accounting principles applied on a consistent
basis during the periods involved (&ldquo;<B>GAAP</B>&rdquo;), except as may be otherwise specified in such financial statements or the
notes thereto and except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly presented in
all material respects the financial position of the Company and its consolidated subsidiaries as of and for the dates thereof and the
results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial,
year-end audit adjustments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(e)
Since the date of the latest financial statements included within the SEC Reports (i) there has been no event, occurrence or development
that has had or that would reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities
(contingent or otherwise) other than (A) liabilities, including trade payables and accrued expenses, incurred in the ordinary course
of business consistent with past practice and (B) liabilities not required to be reflected on a consolidated balance sheet of the Company
pursuant to GAAP or disclosed in filings made with the Commission, (iii) the Company has not altered its method of accounting, other
than the adoption of new accounting standards as set forth in the SEC Reports, and (iv) the Company has not declared or made any dividend
or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any
shares of its capital stock. The Company does not have pending before the Commission any request for confidential treatment of information.
Except for the issuance of the Shares contemplated by this Agreement or any Other Purchase Agreements or as set forth in the SEC Reports,
no event, liability, fact, circumstance, litigation, claim, occurrence or development has occurred or exists or is reasonably expected
to occur or exist with respect to the Company or its subsidiaries or their respective businesses, prospects, properties, operations,
assets or financial condition that would be required to be disclosed by the Company under applicable securities laws at the time this
representation is made or deemed made that has not been disclosed at least one (1) Trading Day prior to the date that this representation
is made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(f)
The Company shall, (i) by 8:30 a.m. Eastern time on the Trading Day immediately following the date of this Agreement, issue a press statement
disclosing the material terms of the transactions contemplated hereby, and (ii) within the time required by the Exchange Act, issue a
Current Report on Form 8-K including the form of purchase agreement and an opinion of legal counsel as to the validity of the Shares
as exhibits thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(g)
The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in
Section 2 of the Securities Act) that would be integrated with the offer or sale of the Shares for purposes of the rules and regulations
of the Trading Market such that it would require shareholder approval prior to the closing of such other transaction unless shareholder
approval is obtained before the closing of such subsequent transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(h)
The Company hereby agrees to use commercially reasonable efforts to maintain the listing or quotation of the Common Stock on the Trading
Market, and concurrently with the Closing, the Company shall apply to list or quote all of the Shares on the Trading Market and promptly
secure the listing of all of the Shares on the Trading Market. The Company will take all action reasonably necessary to continue the
listing and trading of its Common Stock on the Trading Market and will comply in all material respects with the Company&rsquo;s reporting,
filing and other obligations under the bylaws or rules of the Trading Market. The Company shall not take any action which would reasonably
be expected to result in the delisting or suspension of the Common Stock on the Trading Market. The Company agrees to maintain the eligibility
of the Common Stock for electronic transfer through the Depository Trust Company or another established clearing corporation, including,
without limitation, by timely payment of fees to the Depository Trust Company or such other established clearing corporation in connection
with such electronic transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)
No brokerage or finder&rsquo;s fees or commissions are or will be payable by the Company or any of its subsidiaries to any broker, financial
advisor or consultant, finder, placement agent, investment banker, bank or other person with respect to the transactions contemplated
by the Agreement or any of the Other Purchase Agreements. The Purchaser shall have no obligation with respect to any fees or with respect
to any claims made by or on behalf of other persons for fees of a type contemplated in this section that may be due in connection with
the transactions contemplated by this Agreement or any of the Other Purchase Agreements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(j)
The proceeds from the sale of the Shares shall be used by the Company as set forth in the Prospectus Supplement and, for the avoidance
of doubt, the Company shall not use such proceeds in violation of FCPA or OFAC regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(k)
The Company is not, and as a result of the consummation of the transactions contemplated by (i) this Agreement and the application of
the proceeds from the sale of the Shares and (ii) the Other Purchase Agreement and the application of the proceeds from the sale of the
Common Stock thereunder, as set forth in the Base Prospectus and the Prospectus Supplement shall not be, an &ldquo;investment company&rdquo;
or a company &ldquo;controlled&rdquo; by an &ldquo;investment company,&rdquo; within the meaning of the Investment Company Act of 1940,
as amended. The Company shall conduct its business in a manner so that it will not become an &ldquo;investment company&rdquo; subject
to registration under the Investment Company Act of 1940, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(l)
The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and the Company has taken no action designed to,
or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act, nor
has the Company received any notification that the Commission is contemplating terminating such registration. The Company has not, in
the twelve (12) months preceding the date hereof, received notice from any Trading Market on which the Common Stock is or has been listed
or quoted to the effect that the Company is not in compliance in any material respect with the listing or maintenance requirements of
such Trading Market. As of the date hereof, the Company is in compliance with all such listing and maintenance requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(m)
Neither the Company nor any of its officers, directors or Affiliates has, and, to the knowledge of the Company, no Person acting on their
behalf has, (i) taken, directly or indirectly, any action designed or intended to cause or to result in the stabilization or manipulation
of the price of any security of the Company, or which caused or resulted in, or which would in the future reasonably be expected to cause
or result in, the stabilization or manipulation of the price of any security of the Company, in each case to facilitate the sale or resale
of any of the Shares (or any Common Stock issued pursuant to any Other Purchase Agreement), or (ii) sold, bid for, purchased, or paid
any compensation for soliciting purchases of, any of the Shares (or any Common Stock issued pursuant to any Other Purchase Agreement).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>3.2
Representations, Warranties and Covenants of the Purchaser</B>. The Purchaser acknowledges, represents and warrants to, and agrees with,
the Company that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)
At the time the Purchaser was offered the Shares, it was, and as of the date hereof it is an &ldquo;accredited investor&rdquo; as defined
in Rule 501(a) under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)
It has had the opportunity to review this Agreement and the Company&rsquo;s filings with the Commission and has been afforded the opportunity
to ask such questions as it has deemed necessary of, and to receive answers from, representatives of the Company concerning the terms
and conditions of the offering of the Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)
No agent of the Company has been authorized to make and no such agent has made any representation, disclosure or use of any information
in connection with the issue, placement, purchase and sale of the Shares, except as set forth in or incorporated by reference in the
Base Prospectus or the Prospectus Supplement or as otherwise contemplated by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)
(i) The Purchaser has the requisite right, power, authority and capacity to enter into this Agreement and to consummate the transactions
contemplated hereby and has taken all necessary action to authorize the execution, delivery and performance of this Agreement, and (ii)
this Agreement constitutes a valid and binding obligation of the Purchaser enforceable against the Purchaser in accordance with its terms,
except as may be limited by bankruptcy, insolvency, reorganization or other similar laws relating to enforcement of creditors&rsquo;
rights generally and by general principles of equity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(e)
Nothing in this Agreement, the Prospectus, the Disclosure Package or any other materials presented to the Purchaser in connection with
the purchase and sale of the Shares constitutes legal, tax or investment advice. The Purchaser has consulted such legal, tax and investment
advisors as it, in its sole discretion, has deemed necessary or appropriate in connection with its purchase of the Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(f)
Since the time that the Purchaser first began discussions with the Company about the transactions contemplated by this Agreement, the
Purchaser has not directly or indirectly, nor, to its knowledge, has any person acting on behalf of or pursuant to any understanding
with the Purchaser, (i) disclosed any information regarding the Offering to any third parties (other than the Purchaser&rsquo;s legal
and accounting advisors), or (ii) engaged in any transactions in the securities of the Company (including, without limitations, any Short
Sales involving the Company&rsquo;s securities). The Purchaser covenants that, prior to the time that the transactions contemplated by
this Agreement are publicly disclosed, neither it nor any person acting on its behalf or pursuant to any understanding with it will (A)
disclose any information regarding the Offering to any third parties (other than the Purchaser&rsquo;s legal and accounting advisors),
or (B) engage in any transactions in the securities of the Company (including Short Sales).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(g)
The Purchaser&rsquo;s signature page sets forth all securities of the Company held or beneficially owned by such Purchaser as of the
date hereof. The Purchaser does not hold or beneficially own any other securities of the Company, except as indicated on the signature
page hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>ARTICLE
IV</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>MISCELLANEOUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>4.1
Entire Agreement; Modifications</B>. Except as otherwise provided herein, this Agreement constitutes the entire understanding and agreement
between the parties with respect to its subject matter and there are no agreements or understandings with respect to the subject matter
hereof which are not contained in this Agreement. This Agreement may be modified only in writing signed by the Company and the Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>4.2
Survival</B>. All representations, warranties, and agreements of the Company and the Purchaser herein shall survive delivery of, and
payment for, the Shares purchased hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>4.3
Counterparts</B>. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and
the same instrument and shall become effective when counterparts have been signed by each party and delivered to the other party hereto,
it being understood that all parties need not sign the same counterpart. Execution may be made by delivery of a facsimile or PDF.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>4.4
Severability</B>. The provisions of this Agreement are severable and, in the event that any court or officials of any regulatory agency
of competent jurisdiction shall determine that any one or more of the provisions or part of the provisions contained in this Agreement
shall, for any reason, be held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability
shall not affect any other provision or part of a provision of this Agreement and this Agreement shall be reformed and construed as if
such invalid or illegal or unenforceable provision, or part of such provision, had never been contained herein, so that such provisions
would be valid, legal and enforceable to the maximum extent possible, so long as such construction does not materially adversely affect
the economic rights of either party hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>4.5
Notices</B>. All notices or other communications required or permitted to be provided hereunder shall be in writing and shall be deemed
effectively given (i) upon personal delivery to the party to be notified, (ii) when sent by confirmed e-mail if sent during normal business
hours of the recipient, if not, then on the next business day, (iii) five days after having been sent by registered or certified mail,
return receipt requested, postage prepaid, or (iv) one day after deposit with a nationally recognized overnight courier, specifying next
day delivery, with written verification of receipt. All communications shall be sent to the Company or the Purchaser, as applicable,
at the address for such recipient listed on the signature pages hereto or at such other address as such recipient has designated by two
days advance written notice to the other party hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>4.6
Governing Law</B>. This Agreement shall be governed by, and construed in accordance with, the internal laws of the State of Delaware
without regard to the choice of law principles thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>4.7
WAIVER OF JURY TRIAL</B>. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES
EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY
AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>4.8
Headings</B>. The headings of the various sections of this Agreement have been inserted for convenience of reference only and will not
be deemed to be part of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>4.9
Fees and Expenses</B>. Each party shall pay the fees and expenses of its advisers, counsel, accountants and other experts, if any, and
all other expenses incurred by such party incident to the negotiation, preparation, execution, delivery and performance of this Agreement.
The Company shall pay (a) all transfer agent fees incurred in connection with the delivery of any Shares to the Purchaser and (b) all
out-of-pocket expenses (including reasonable attorney&rsquo;s fees) of the Purchaser incurred by the Purchaser in connection with specifically
enforcing the terms and provisions of this Agreement pursuant to Section 4.10.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>4.10
Enforcement</B>. The Company and the Purchaser acknowledge and agree that irreparable damage would occur in the event that any of the
provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly
agreed that either party shall be entitled to an injunction or injunctions to prevent or cure breaches of the provisions of this Agreement
by the other party and to enforce specifically the terms and provisions hereof (without the necessity of showing economic loss and without
any bond or other security being required), this being in addition to any other remedy to which either party may be entitled by law or
equity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>4.11
Termination</B>. This Agreement may be terminated by the Company or the Purchaser, by written notice to the other party, if the Closing
has not been consummated on or before the third (3rd) Trading Day after the parties&rsquo; execution of this Agreement; provided, however,
that no such termination will affect the right of any party to sue for any breach by any other party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>4.12
</B>&nbsp;<B>Independent Nature of Purchaser&rsquo;s Obligations and Rights</B>. The Purchaser shall not be responsible in any way for
the performance or non-performance of the obligations of any Other Purchaser under any Other Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">[<I>Signature
Pages Follow</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">IN
WITNESS WHEREOF, the parties hereto have executed this Agreement effective as of the date first written above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>STREAMLINE HEALTH SOLUTIONS,
  INC.</B></FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>

<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>

<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: justify"></TD></TR>

<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Title:</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: justify"></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify; width: 50%"></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Address for notice:</FONT></TD></TR>

<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Streamline Health Solutions, Inc.</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">2400 Old Milton Pkwy Box 1353</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Alpharetta, GA 30009</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Attention: Chief Financial Officer</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Email: Thomas.Gibson@streamlinehealth.net</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">With a copy (which shall not constitute notice)
  to:</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Troutman Pepper Hamilton Sanders LLP</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">600 Peachtree St NE, Suite 3000</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Atlanta, GA 30308</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Attention: David W. Ghegan</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">E-mail: David.Ghegan@troutman.com</FONT></TD></TR>
</TABLE>

<P STYLE="font-family: Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">[<B>PURCHASER</B>]</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Title:</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Address for notice:</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Email:</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2.5in; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Company
Shares currently held by Purchaser: ________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name
of DTC Participant (broker-dealer at which the account or accounts to be credited with the Shares are maintained): ________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">DTC
Participant Number: ________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name
of Account at DTC Participant being credited with the Shares: ________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Account
Number at DTC Participant being credited with the Shares: ________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 9; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: left"><IMG SRC="logo.jpg" ALT="" STYLE="height: 57px; width: 210px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; width: 50%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR
    IMMEDIATE RELEASE</B></FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Streamline
Health&reg; Announces Registered Direct Offering of Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Atlanta,
GA &ndash; October 25, 2022 &ndash; <U>Streamline Health Solutions, Inc.</U></B> (&ldquo;Streamline&rdquo; or the &ldquo;Company&rdquo;)
(Nasdaq: STRM), a leading provider of solutions that enable healthcare providers to proactively address revenue leakage and improve financial
performance, today announced that it has entered into purchase agreements to sell a total of 6,299,989 shares of common stock in a registered
direct offering to certain investors at a purchase price of $1.32 per share, which represents the closing price on The NASDAQ Capital
Market on October 24, 2022. The offering is being made without an underwriter or placement agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
gross proceeds to Streamline from the offering are expected to be approximately $8.3 million. The offering is expected to close on or
about October 26, 2022, subject to satisfaction of customary closing conditions. Streamline intends to use the proceeds from the offering
for general corporate purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares described above are being offered by Streamline pursuant to a shelf registration statement on Form S-3 previously filed with and
subsequently declared effective by the Securities and Exchange Commission (&ldquo;SEC&rdquo;) on September 13, 2022. The prospectus supplement
and accompanying base prospectus relating to the offering will be filed with the SEC and will be available on the SEC&rsquo;s website
at <U>www.sec.gov</U>. Alternatively, a copy of the prospectus supplement and accompanying prospectus may be obtained from the Company
at: Streamline Health Solutions, Inc., Attention: Corporate Secretary, 2400 Old Milton Pkwy, P.O. Box 1353, Alpharetta, GA 30009, or
by telephone at (888) 997-8732.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release shall not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein, nor
shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful
prior to registration or qualification under the securities laws of any such state or jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Safe
Harbor Statement under the Private Securities Litigation Reform Act of 1995</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
document may contain certain &ldquo;forward-looking statements&rdquo; within the meaning of the Private Securities Litigation Reform
Act of 1995. These include statements regarding, but not limited to, the anticipated closing of the offering and Streamline&rsquo;s expected
uses of the proceeds from the offering. Forward-looking statements can be identified by the use of words such as &ldquo;may,&rdquo; &ldquo;will,&rdquo;
&ldquo;plan,&rdquo; &ldquo;should,&rdquo; &ldquo;expect,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;estimate,&rdquo; &ldquo;continue&rdquo;
or comparable terminology. Forward-looking statements involve risks and uncertainties that could cause actual results or developments
to differ materially from those indicated due to a number of factors affecting Streamline&rsquo;s operations, markets, products and services.
Streamline identifies the principal risks and uncertainties that impact its performance in its public reports filed with the SEC, including
the &ldquo;Risk Factors&rdquo; and &ldquo;Management&rsquo;s Discussion and Analysis of Financial Condition&rdquo; sections of Streamline&rsquo;s
most recent Annual Report on Form 10-K, as may be supplemented or amended by Streamline&rsquo;s subsequent Quarterly Reports on Form
10-Q. Forward-looking statements speak only as of the date on which they are made and Streamline undertakes no obligation to publicly
release the results of any revision to such forward-looking statements, which may be made to reflect events or circumstances after the
date hereof or to reflect the occurrence of unanticipated events, except as required by applicable law.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Streamline Health</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Streamline
Health Solutions, Inc. (Nasdaq: STRM) enables healthcare organizations to proactively address revenue leakage and improve financial performance.
We deliver integrated solutions, technology-enabled services and analytics that drive compliant revenue leading to improved financial
performance across the enterprise. For more information, visit <U>www.streamlinehealth.net</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Company
Contact</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jacob
Goldberger</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director,
Investor Relations and FP&amp;A</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">303-887-9625</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Jacob.goldberger@streamlinehealth.net</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>5
<FILENAME>ex99-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibitb
99.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 49%"><IMG SRC="logo.jpg" ALT="" STYLE="height: 57px; width: 210px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR
    IMMEDIATE RELEASE</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Streamline
Health<SUP>&reg;</SUP> Announces Strategic Alignment and Closing of Registered Direct Offering of Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company
    closed the previously announced registered direct offering of common stock for gross proceeds of approximately $8.3 million; more
    than 30% was raised from insiders</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ben Stilwill appointed
    President, Streamline Health Solutions, Jawad Shaikh appointed Chief Strategy Officer, Streamline Health Solutions, Amy Sebero appointed
    Chief Growth Officer, Streamline Health</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company anticipates
    exiting fiscal 2022 with $17 million of booked SaaS ACV, and exiting fiscal 2023 with $30 million of booked SaaS ACV</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Atlanta,
GA &ndash; October 27, 2022 &ndash; <U>Streamline Health Solutions, Inc.</U></B> (&ldquo;Streamline,&rdquo; &ldquo;Streamline
Health,&rdquo; or the &ldquo;Company&rdquo;) (Nasdaq: STRM), a leading provider of solutions that enable healthcare providers to proactively
address revenue leakage and improve financial performance, today announced a strategic alignment of its business and the closing of its
previously announced registered direct offering of common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Strategic
Alignment</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has consolidated its eValuator and Avelead businesses into one organization. The Company believes the alignment will accelerate
progress within its innovation and service functions. The eValuator and Avelead software solutions share a common call point; as a result,
the Company expects this alignment will enhance growth and profitability over the long term.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
immediately, Ben Stilwill has been appointed President, Streamline Health; Jawad Shaikh has been appointed Chief Strategy Officer, Streamline
Health and Amy Sebero has been appointed Chief Growth Officer, Streamline Health.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ben
Stilwill has most recently served as CEO, eValuator Solutions and, prior to that, as Streamline&rsquo;s Senior Vice President of Customer
Success. Ben was instrumental in developing a world class client success organization within eValuator focused on maintaining key client
relationships and establishing a portfolio of referenceable accounts. Mr. Stilwill joined Streamline in 2013 as a senior financial analyst
and has held various roles in finance, infrastructure and sales. Prior to joining Streamline Health, Mr. Stilwill was an analyst in BMO
Capital Markets M&amp;A practice. Mr. Stilwill holds an Executive MBA from Villanova University and a bachelor&rsquo;s degree in economics
from DePauw University.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;I
am thrilled to continue to lead and evolve the culture of excellence we have developed at Streamline. Our team is focused on helping
our country&rsquo;s health systems get paid for the care they provide by optimizing revenue integrity prior to billing. These moves help
us further pursue that mission.&rdquo; stated Ben Stilwill, President, Streamline Health.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jawad
Shaikh was previously CEO, Avelead Solutions, which he cofounded in 2014. Jawad was also the founder and senior partner of Accision Health,
a Health IT service and consulting firm, from 2000-2010 prior to its merger with Parallon Technology Solutions. Jawad&rsquo;s vision
for delivering solutions in the form of healthcare technology-specific services and customized healthcare software offerings has delivered
results for clients nationally.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;I
am excited to have the opportunity to work with the entire Streamline Health team to help our health system clients put an end to lost
revenue.&rdquo; Said Jawad Shaikh, Chief Strategy Officer, Streamline Health.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amy
Sebero has more than four decades of healthcare experience and has been the Chief Growth Officer of eValuator since March of 2022. Prior
to joining Streamline, Amy was nThrive&rsquo;s Chief Client Officer and Chief Growth Officer, managing relationships with over 900 health
systems, including 37 of the 40 largest healthcare providers in the U.S. She was with nThrive for more than 28 years. Prior to joining
nThrive, Ms. Sebero spent 10 years as a CPA in healthcare auditing and consulting at Ernst &amp; Young. Ms. Sebero holds a bachelor&rsquo;s
degree in accounting from the University of North Florida.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;My
career has been dedicated to improving the financial well-being of healthcare organizations, allowing them to better serve their patients
and communities. I believe the solutions we offer at Streamline have significant value for any health system and I am thrilled to lead
our combined growth function.&rdquo; Said Amy Sebero, Chief Growth Officer, Streamline Health.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;I
am thrilled to work with Ben to lead our organization in providing world class solutions to our clients.&rdquo; Commented Tee Green,
Chief Executive Officer, Streamline Health Solutions. &ldquo;Thanks to the execution of this strategic alignment, we continue to expect
to achieve cash generation during the second half of fiscal 2023, while continuing to make strides within each of innovation, service
and growth.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the consolidation of the eValuator and Avelead businesses, the Company expects to realize approximately $1.5 million of annualized
cost savings as of November 1, 2022; with an additional $1.5 million of annualized cost savings to be realized through future actions
executed throughout fiscal 2023. More than 10% of these cost savings are expected to be attributable to salary reductions from the Company&rsquo;s
executive management. Streamline maintained its previous expectation to exit fiscal 2022 with $17.0 million of Booked SaaS ACV and announced
that it expects to exit fiscal 2023 with $30.0 million of Booked SaaS ACV.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stock
Offering</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also announced that it had closed its previously announced registered direct offering to sell a total of 6,299,989 shares of
common stock to certain investors at a purchase price of $1.32 per share, which represents the closing price on The NASDAQ Capital Market
on October 24, 2022. The offering was made without an underwriter or placement agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
gross proceeds to Streamline from the offering totaled approximately $8.3 million. Streamline intends to use the proceeds from the offering
for general corporate purposes. More than 30% of the offering was raised from insiders, including each member of the company&rsquo;s
board of directors and key members of the company&rsquo;s management team.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chad
Nelson, Managing Partner at Invenire Capital, commented, &ldquo;Streamline&rsquo;s ability to execute is evidenced by rapid bookings
growth throughout fiscal 2022. We are confident in the value the Company&rsquo;s solutions provide to health systems and the talented
team at the Company; our investment reflects our belief in Streamline&rsquo;s long-term potential.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares described above were offered by Streamline pursuant to a shelf registration statement on Form S-3 previously filed with and subsequently
declared effective by the Securities and Exchange Commission (&ldquo;SEC&rdquo;) on September 13, 2022. The prospectus supplement and
accompanying base prospectus relating to the offering were filed with the SEC and are available on the SEC&rsquo;s website at <U>www.sec.gov</U>.
Alternatively, a copy of the prospectus supplement and accompanying prospectus may be obtained from the Company at: Streamline Health
Solutions, Inc., Attention: Corporate Secretary, 2400 Old Milton Pkwy, P.O. Box 1353, Alpharetta, GA 30009, or by telephone at (888)
997-8732.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release shall not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein, nor
shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful
prior to registration or qualification under the securities laws of any such state or jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Safe
Harbor Statement under the Private Securities Litigation Reform Act of 1995</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
document may contain certain &ldquo;forward-looking statements&rdquo; within the meaning of the Private Securities Litigation Reform
Act of 1995. These include statements regarding, but not limited to, the anticipated closing of the offering and Streamline&rsquo;s expected
uses of the proceeds from the offering. Forward-looking statements can be identified by the use of words such as &ldquo;may,&rdquo; &ldquo;will,&rdquo;
&ldquo;plan,&rdquo; &ldquo;should,&rdquo; &ldquo;expect,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;estimate,&rdquo; &ldquo;continue&rdquo;
or comparable terminology. Forward-looking statements involve risks and uncertainties that could cause actual results or developments
to differ materially from those indicated due to a number of factors affecting Streamline&rsquo;s operations, markets, products and services.
Streamline identifies the principal risks and uncertainties that impact its performance in its public reports filed with the SEC, including
the &ldquo;Risk Factors&rdquo; and &ldquo;Management&rsquo;s Discussion and Analysis of Financial Condition&rdquo; sections of Streamline&rsquo;s
most recent Annual Report on Form 10-K, as may be supplemented or amended by Streamline&rsquo;s subsequent Quarterly Reports on Form
10-Q. Forward-looking statements speak only as of the date on which they are made and Streamline undertakes no obligation to publicly
release the results of any revision to such forward-looking statements, which may be made to reflect events or circumstances after the
date hereof or to reflect the occurrence of unanticipated events, except as required by applicable law.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Streamline Health</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Streamline
Health Solutions, Inc. (Nasdaq: STRM) enables healthcare organizations to proactively address revenue leakage and improve financial performance.
We deliver integrated solutions, technology-enabled services and analytics that drive compliant revenue leading to improved financial
performance across the enterprise. For more information, visit <U>https://streamlinehealth.net/.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Company
Contact</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Media:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
Kosloski</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vice
President, Marketing and Communications</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">651.308.1395</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>david.kosloski@streamlineheath.net</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investors:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jacob
Goldberger</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director,
Investor Relations and FP&amp;A</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">303-887-9625</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Jacob.goldberger@streamlinehealth.net</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>ex5-1_001.jpg
<TEXT>
begin 644 ex5-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  Z (\# 2(  A$! Q$!_\0
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MP>?]D5W%O\+M2U+5K:]\5^(I-4CMFW) %(4GK@Y/ X[#FJ/P/_YF/_KXC_\
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'***S,3__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>logo.jpg
<TEXT>
begin 644 logo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 Z17AI9@  34T *@    @  U$0  $
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZ@X07L\3!7E3;OI_-%_:C?YIZ-;-]11117QY^J!1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !7P7_P<K_\HC/'G_82TC_TX05]Z5\%_P#!RO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^"_P#@Y7_Y
M1&>//^PEI'_IP@K[TKX+_P"#E?\ Y1&>//\ L):1_P"G""OI.#?^1]@_^OL/
M_2D=F7_[U3_Q+\S^8^BBBO[@/TP**** "BBB@ HHHH _0_\ X-D_VFG^!?\
MP4KTWPS<W'E:/\4=,N-"F5SB-;E%-S;.?]HO"T2^]P?J/Z5:_C3_ &8_BW-\
M _VC_ /CB"1H9/"/B&PUC<N3Q!<)*00.H(4@C!R"1@YK^RJ*59HU=&5T<!E9
M3D,#W%?S+XV9:J69T<;%?Q(M/S<'O]TDOD?%\24>6M&HOM+\O^''4445^*GS
M84444 %?EY_P5_\ &$FO_M50Z;N_<Z#H]O;A!T#R%YF;ZD.@^BBOU#K\G_\
M@JM&R?MH^("RLH>TLBI(^\/LZ#C\0?RK](\*Z<99TV^D)-??%?DV?S]])2O.
MGPE&,-I5H)^G+.7YI'SG1117]&'\$!1110 4444 %%%% !1110!]Y?\ !$SQ
M8XN?'^A.V8V6SOXE_ND&5'/3OF/OV[]OOJOSH_X(IPR-\5O&D@9O+728E9=O
M!)FX.?;!X[Y/I7Z+U_,GB-3C'/ZW+U47_P"2H_T3\ :\ZG!.%4_LNHEZ>TD_
MUL%%%%?#'[*%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KX+_X.5_\ E$9X\_["6D?^
MG""OO2O@O_@Y7_Y1&>//^PEI'_IP@KZ3@W_D?8/_ *^P_P#2D=F7_P"]4_\
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M#X92LO1:+[TDS_4#PWX=GD?#6#RRJK3A"\EVE)N<E\I2:^04445X!]L%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7D. 9+&^B0?5F@"CZDBNW\&?\%7OV:?'TT<>F_'7X7^;,<1QW?B"WLW<[@H
M69D)8DC ZGMD45.'\UIJ]3#5$O.$E^@2PE=;P?W,^@J*Q?!/Q'\._$O3/MWA
MO7M%\06>%;[1IM[%=Q8;D'=&Q'../6MJO)E&47RR5F<[36C"BBBI **** "B
MBB@ HHHH **** "BBB@ HJKJVM6>@VOGWUW:V<.X+YD\JQKD]!EB!FN'U?\
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M^Q)TS_TG6OQ'QP_Y%V'_ ,;_ /26?,\3?P8>OZ'T11117\TGQH4444 %%%%
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M^_DS]LO^(Q/_ *MU_P#+]_\ O=1_Q&)_]6Z_^7[_ />ZOQ-HK[?_ (A7PO\
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MFW9Z8P,>M?(-%<.99;ALPPT\'BX\U.6ZNU?6^Z:>ZZ,RK4858.G45TS]LO\
MB,3_ .K=?_+]_P#O=1_Q&)_]6Z_^7[_][J_$VBOC/^(5\+_] O\ Y/4_^3/.
M_L/ _P GXO\ S/WX^&/_  =S_"?6[I8_%WPO\?>'48X\W3;FUU14]SO: X^@
M)]J^UOV5_P#@K_\ LZ_MCWMOI_@OXF:+_;ER $T?5@^EW[.<?(D=P$\YN?\
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MT?>CY;_=_P .?I5138)X[J!)(W62.10R.IW*P/((/<&G5^8GBA1110 4444
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MBR#&Y_YZ1%'Z<D<5_0U_P2\_X+/?#'_@IAX?CT^PD'A/XD6D'FZAX6OIPTK
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MI<^)U?9?J_\ (^V/VG/^#@W]J+]I>6XA'CQO .D3$[=/\(1'3/+'M<Y:Z_\
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M,;X#_P#8DZ9_Z3K7XCXX?\B[#_XW_P"DL^9XF_@P]?T/HBBBBOYI/C0HHHH
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M%U(6N+U@,E(($!EF8==L:L0.3@<U\)_\%@?^#AOPW^Q9>ZI\._A2FG^,?BA
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MF([OX8_X4^O]YZ]K'W.6Y+3PZ4ZGO3_!>G^84445^GGMA1110 4444 %%%%
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M3G_@I]<_\%*OA-\$Y_$5K)!X_P# =AJ.F^(ITB5+?4FD:V,-U&%X4R+&V]
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M3]M47O/\%_GW^X****_6SWPHHHH **** "BBB@ HHHH **** "OV(_X(/_\
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M?_ NS7T60Y6FOK55>B_7_+[PHHHK^@#ZP**** "BBB@ HHHH **** "BBB@
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M[@O_ *?-/K^72OZB\$O^1'5_Z^R_](IGV_#7^ZR_Q/\ )!1117[$?0A1110
M5J>"_&NL?#CQ9IVO>']3OM%UK29UNK*^LIFAN+653E71U(*L#W%9=%3**DN6
M2NF&^C/Z7/\ @AG_ ,%H;/\ X*+> W\%^-I+33OC!X9M!+<A (X?$ELN%-Y"
MHX6125$L8X!8,ORDK'^A%?QF?L_?'CQ+^S'\:/#?C[P?J$FF^(O"U\E]9S+]
MTE3\T;C^*-U+(RGAE9@>#7]</[%7[5FA?MM?LO>#_B=X=Q'8^*+%9I;8OO:P
MN5)2>W8]VCE5TSQD*#T(K^5/%'@F&3XE8W!*U"J]ND9;V]&M5VLULD?"YWEJ
MP\_:4_AE^#_K8]2K\@_^#@K_ (+E7'P.DU3X%_!W5UB\731FW\5>(;20^9H2
ML.;.W8<"Y93\\@.8@=HQ)DQ_5O\ P7"_X*8)_P $X/V2I;K19HC\1O&[2:7X
M8B8!OLS!09[U@>"L"LN <YDDB!!4L1_+IK6LWGB/6+O4-0NKB^O[^9[BYN)Y
M#)+<2NQ9W=CRS,Q))/))KU?"G@6&.E_;&/C>E%^Y%[2DMV^\8O2W5[Z*SVR+
M*U5?UBJO=6R[O_)%9F+L68EF8Y)/>DHHK^F#[0**** "BBB@ HHHH **** "
MBBB@"2VNI+*YCFADDAFA8.CHQ5D8'(((Y!![U^\'_!!;_@O;<?'#4M)^"7QM
MU59/%T@6U\,>)[E@O]M;5PMG=,>/M.!A)3_KC\K?O<&7\&ZDMKJ2RN8YH9)(
M9H6#HZ,59&!R"".00>]?-<4<+X//<&\+BEK]F76+[KR[K9KSLUQX[ T\53Y)
M_)]C^V"BOSL_X-^_^"MK?M\?!.3P+XWU!9/BQX#M4%S/*_[SQ%8 A$O>>3*I
M*I-ZLR/_ ,M"J_HG7\:9UD^)RO&SP.+5IP?R:Z->36J_S/SK$8>="HZ53=!1
M117EF 4444 %%%% !1110 4444 %?$__  52_P""WGPW_P"":VE3:#'Y?C3X
MI7$ >T\-VDX5;'<,K+>RC/DI@[@@!D<%<*%.\?/'_!<+_@X"M_V8IM7^$7P5
MOK>^^(B@VVM^(8]LUOX9)R&AAZK)=CN3E8CP=SY5/P(\2^)=1\9>(;[5M7OK
MS5-4U*=[F[O+N9II[J5R69W=B69B2223DDU^U< ^%L\?&.89NG&D]8PV<EW?
M51?3J]]%9OZ3*LC=5*MB-(]%U?\ P#UO]M?_ (*!_%3_ (* ?$9O$7Q)\27&
MIK"['3]*AS#IND(W\%O #M7@ %SEVP"S,>:\6HHK^DL+A:.&I1H8>*C".B25
MDODC[*G3C"/+!604445T%!1110 4444 %%%% !1110 4444 %%%% %C2M5NM
M"U.WO;&YN+.\M9%E@G@D,<L+J<JRL,%6!Y!'(K]@/^"3O_!S1K'@&YTWP%^T
M;=76O:"Q2WLO&JQF74-/&< 7RKS<1@8_>J#*,$L)2<K^.]%>#Q!PWE^<X?ZO
MCH7[/:47WB^GIL^J9RXO!TL3#DJKY]5Z']J7@_QCI/Q"\+:?KF@ZE8ZSHNK0
M)=65]93K/;W<3C*NCJ2K*1R"#BM*OY?O^"/W_!:GQA_P38\;6^@:Q)?>)OA#
MJER#J6B,Y>72MQ.ZYL=QPCY;<T?"2XP=K8=?Z6_@W\9/#'[07PQT7QEX-UJS
M\0>&?$%NMU8WUJVZ.9#P01U5E(*LC ,K*5(!!%?R;QEP3C.'\1RU/>I2^&:6
MC\GVEY==UUM\'F.6U,).SUB]G_74Z:BBBOBSS0HHHH *_+;_ (.1O^"K\_[*
MOPH3X,^ M2:V^('CRS+ZO?6TF)=!TMLJ0I!RD]QAE4]5C#L-K-&U?H[\=?C+
MHO[/'P8\4^.O$4Q@T/PCI=QJMXRXW-'#&7*KD@%VQM4=V8#O7\@_[4_[1_B'
M]KK]H;Q=\2/%$QEUKQ;J$E[*@8LEK&?EB@0GGRXHU2-<\[4%?K'A/PG#-,P>
M-Q,;TJ-G9[2GT7FEN_DGHSWLAP"KU?:S^&/XOH>?T445_5A]T%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 ?ME_P &L_\ P4MN+BZO/V;_
M !=?23+LFU7P5//)DQA1YEUIXSVQNG0#IB?)^Z!^V5?QB_ _XQZ[^SU\8?#/
MCGPS=&SU_P )ZE#J=C+SM$D3A@K#^)&P59>C*Q!X-?V"?LW_ !UT?]ISX!^#
M_B%H)/\ 9/C'2;?5;="P9H/-0,T3$?QHVY&_VE-?R[XP<,QP6/CF5!6A6OS>
M4UO_ .!+7U4F?$<08)4JJK0VEOZ_\'_,[:BBBOQT^>.3^.WP@TO]H'X*>+?
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M$?RY?'CX\>+/VF?BSK7CCQQK5WX@\3>()S<7EY<'ECT5%4<)&J@*J* JJ
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MJ4K/_#+_ "DE;U9\WQ)AU*C&LMXO\'_P3],Z***_F0^+"BBB@ HHHH ^)O\
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MVUIVFOD[/_R5L\C/*/M,'+RL_P"OD?T"4445_'Y^?!2,H=2K ,K#!!'6EHH
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M9?G./I5\NGS1C"S=FM>9OJET9\SGF,I8BK&5%W27ZA1117YB>*?AC_P>!_\
M)2/@7_V#=8_]&VE?C37[+?\ !X'_ ,E(^!?_ &#=8_\ 1MI7XTU_8_AC_P D
MQA?27_I<C]$R7_<H?/\ -A1117WIZ@4444 %%%% !5[1/$^H>&TOET^\N+,:
ME:M977E/M\^%BI:-O525&1WQ5&BE**:LPW"BBBF 4444 %%%% !1110 5L?#
M_P  :W\5?&VE^&_#>EWVMZ]K=REG86%G$99[J9SA451R2376?LQ?LG?$+]LC
MXG6WA#X;^%]2\3ZU<$%UMTQ#9QDX\V>5L)#&/[SD#MR2!7]&7_!'C_@B'X5_
MX)I:%_PD^O7%GXN^+FJ6_E7>K)&?LFC1L/GM[(, P!Z-,P#N!C"*2I^)XRXX
MP.0T'SM2K->[!/7UEVCY]>ESS<PS.EA8ZZRZ+_/R.O\ ^",G_!,*Q_X)F_LO
MQZ7J'V2]^(GBMDO_ !3J$/S()0#Y=I$W>*$,P!_B=I&X# #Z_HHK^/\ ,\RQ
M&/Q4\9BI<TYN[?\ EY+9+HM#\^K5IU9NI/=A1117"9!7\Z?_  <J_P#!3!_V
MI/VD?^%1>%=0\SP'\,+IX[UX9-T6K:P 4ED..JP M"O^UYQY#+C]?O\ @L_^
MW@W_  3\_80\3>*M-N%A\8:X1H'AGH62^G5OWX!_YXQ+)+R""T:J?O5_*;<W
M4E[<R3322333,7=W8LSL3DDD\DD]Z_>/!KA95:LL[Q"T@^6'^+[4ODG9>;?5
M'U'#N!YI/$SZ:+UZLCHHHK^C#[ **** "BBB@ HHHH ***Z;X4_!;QA\=O%"
M:)X)\*^(?%VL2 $6>CZ?+>SXSC)6-20ON>!45*D81<YM)+=O1"<DE=G,T5]\
M?!C_ (-JOVK/BW;0W%]X4T#P/:W!&R3Q%K44;!3_ !-%;^=*N/1D#<=.F?=/
M#W_!HG\6[FR#:M\5/AS97&!E+2"\ND!QS\S1QG@]/EY]NE?*8KCSA[#RY:F+
MA?R?-_Z3<X*F:82#LZB_/\C\DZ*_5WQI_P &C_QLTRV>30?B-\,=89%W".[>
M]LF<X.5&()!GH!D@<\D8KYF^/_\ P01_:I_9ZM);R]^%VH^)M-B_Y>O#$\>L
M;O7]Q"3< #KDQ >_7&N"XVR'%RY*&*A=]&^5OT4K%4\RPM1VC47Y?F?'=%6-
M4TJZT/49K.^MKBSO+9S'-!/&8Y(F'564X((]#5>OJ4[ZH[@HHHH **** "BB
MB@ HHHH _=__ (-9O^"C\GQ \!:C^SSXJOC)JGA6&35/"<T\GS3V!<&>S!/)
M,+OO0<GRY' PL0K]A:_C9_9;_:(U[]DW]HCP?\2/#<ICUCPAJ<5_$NXJMP@.
M)8'QSLEC+QMCJKM7]?\ \%?B[HOQ^^$/AGQQX;N/M6@^+-,M]6L9#C<8IHU=
M0P_A<;L,O56!!Y%?ROXN\,K+\R684%:G7NWY37Q?^!?%Z\Q\-Q!@O95O:QVE
M^?7[]_O.GHHHK\C/ "BBB@ KY;_X+!_\% K?_@G1^Q7KWB^UD@;QAK!_L;PM
M;2 -YE_*K$2LO=(45Y6SP=BKD%Q7U)7\SO\ P<;_ +=;?M<_MZZAX8TF]DF\
M&_"42>'[%%DW0SWP?_3K@#IDR*L.1P5MD/<U]UX=\,K.LWA2JJ]*'O3\TMH_
M]O.R]+]CU,HP?UG$*,OA6K_R^9\#ZYKEYXFUJ\U+4KJXO]0U"=[FZN;B0R37
M$KL6=W8\LS,223R22:JT45_9222LC]$"BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#^J[_@A-\2&^*7_!)GX+
MZA)*9);'2)=';)RR"RNI[15/I\D*X]B*^MJ_.[_@U[\1?VW_ ,$J]+MO-:3^
MQ_$NJ6FTKCRLNDVT>O\ KLY_VL=J_1&OX=XNPZH9WBZ2V52=O1R;1^9YA'EQ
M-2*[O\PHHHKYTXPHHHH *_G[_P"#N;_D]7X:_P#8DC_TONJ_H$K^?O\ X.YO
M^3U?AK_V)(_]+[JOT[PB_P"2DI_X9_D>UP__ +XO1_D?D_1117];'WP4444
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M+'61&2.MI</"2.__ "^@'''3/:OQ[K]*/^#5;Q,="_X*=WEJ)&3^VO!6HV1
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M-(0<$"WC[/7T'"^0U,XS.E@*>TG[S[16LG]VWG9'5@<*\16C277?TZGY,?\
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M?:A@'@9/J:_'2O[,\-ZBGPUA''^5K[I27Z'Z+D[O@X6[?JPHHHK[@],****
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MI_Z5&OAO$K_DFL5Z+_TJ)Y>=?[E/Y?FC]Z****_C0_.PHHHH **** "BBB@
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M3_PS_(]KA_\ WQ>C_(_)^BBBOZV/O@HHHH **** "BBB@ HHHH **[3]GO\
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MK)&PP5="58'(-<37[/1K0JP56DU*+5TUJFGLT^J/HHR4ES1V"BBBM"@HHHH
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M?O\ E*OI'_8MZI_Z+6OSPK]#_P#@U^_Y2KZ1_P!BWJG_ *+6OE^-O^1!C/\
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MRL&5F4_RG_M[_L2>+/\ @GW^TSKWPW\6)YTVGL+C3=12,I#K%BY/DW48YP&
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M^DZU^(^.'_(NP_\ C?\ Z2SYGB;^##U_0^B****_FD^-"BBB@ HHHH _F/\
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M0,\;2>!/^"N/P;ND9MMY?W>FR*,X=;BPN8 " 1D!G5N> 5!P<8K^J*OY$/\
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MGQO]DXS_ )]L_4:BORY_XBU_V<?^A*^-G_@GTS_Y84?\1:_[./\ T)7QL_\
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M1\</^1=A_P#&_P#TEGS/$W\&'K^A]$4445_-)\:%%%% !1110!_,?_P<K_\
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M:]H.L0-;7VGW]NL]O=1GJKHP(([\]" >M?><%\?8W(*G(O?H2?O0;_&+Z/\
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MVBV_PI^)]Y;V_P 6M)M2;#4&*QIXMMXU)9@. +I%4LZCAU!=0,.%_3BOXL/
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M_,\QE?%5'_>?YA7SS_P5JB:;_@F1\>%568_\(1JC8 SP+=R3^ !-?0U>1_\
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M_!E!_"O;X9ERYOA6_P#G[3_]*1TX/_>(?XE^9_*)1117]TGZ>%%%% !1110
M4444 %?U%_\ !NG_ ,H;O@[_ -QK_P!/FH5_+I7]1?\ P;I_\H;O@[_W&O\
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MBB@ HHHH _K!_P""*7_**CX'_P#8MQ_^C)*^HZ^7/^"*7_**CX'_ /8MQ_\
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M<;A*F%Q%3#5?BA)Q?JG9GYA4IN$W"6Z=@HHHKE("BBB@ HHHH _ET_X.+/\
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MG]DT$$=K D<:+''&H5$4;54#@ #L!3J**_@$_*0HHHH **** "BBB@ HHHH
M**** "OP]_X._P#X9-!XH^"/C*.+<MU:ZIHMS(%^X8WMYH5)]_-G('^R?6OW
M"K\W_P#@Z1^")^)O_!,M_$D,9:X^'?B2QU9W'403%[)UQZ%[F)CW&STSG[?P
MXQRPO$>%F]I2<?\ P-.*_%H]+)ZOL\9!^=OOT/YNZ***_LT_1@HHHH ****
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M /XU7]B=%'_$<L7_ - L?_ G_D'^LU3^1?>?QV?\,/?&K_HC_P 4?_"5O_\
MXU1_PP]\:O\ HC_Q1_\ "5O_ /XU7]B=%'_$<L7_ - L?_ G_D'^LU3^1?>?
MQV?\,/?&K_HC_P 4?_"5O_\ XU1_PP]\:O\ HC_Q1_\ "5O_ /XU7]B=%'_$
M<L7_ - L?_ G_D'^LU3^1?>?QV?\,/?&K_HC_P 4?_"5O_\ XU1_PP]\:O\
MHC_Q1_\ "5O_ /XU7]B=%'_$<L7_ - L?_ G_D'^LU3^1?>?QV?\,/?&K_HC
M_P 4?_"5O_\ XU1_PP]\:O\ HC_Q1_\ "5O_ /XU7]B=%'_$<L7_ - L?_ G
M_D'^LU3^1?>?QV?\,/?&K_HC_P 4?_"5O_\ XU1_PP]\:O\ HC_Q1_\ "5O_
M /XU7]B=%'_$<L7_ - L?_ G_D'^LU3^1?>?QV?\,/?&K_HC_P 4?_"5O_\
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MC7"_]?(?^E(Z,'_'AZK\S^3ZBBBO[L/U **** "BBB@ HHHH *_J+_X-T_\
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M4-WQB_[@O_I\T^OY=*_J+_X.+/\ E#=\8O\ N"_^GS3Z_ETK^HO!+_D1U?\
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MQUQ1B,AP,<;0I*HN91=VU:Z=GHGU5OFCS<TQT\+256,;ZV/YU?\ AA[XU?\
M1'_BC_X2M_\ _&J/^&'OC5_T1_XH_P#A*W__ ,:K^Q.BOR;_ (CEB_\ H%C_
M .!/_(\'_6:I_(OO/X[/^&'OC5_T1_XH_P#A*W__ ,:H_P"&'OC5_P!$?^*/
M_A*W_P#\:K^Q.BC_ (CEB_\ H%C_ .!/_(/]9JG\B^\_CL_X8>^-7_1'_BC_
M .$K?_\ QJC_ (8>^-7_ $1_XH_^$K?_ /QJO[$Z*/\ B.6+_P"@6/\ X$_\
M@_UFJ?R+[S^.S_AA[XU?]$?^*/\ X2M__P#&J/\ AA[XU?\ 1'_BC_X2M_\
M_&J_L3HH_P"(Y8O_ *!8_P#@3_R#_6:I_(OO/X[/^&'OC5_T1_XH_P#A*W__
M ,:H_P"&'OC5_P!$?^*/_A*W_P#\:K^Q.BC_ (CEB_\ H%C_ .!/_(/]9JG\
MB^\_CL_X8>^-7_1'_BC_ .$K?_\ QJC_ (8>^-7_ $1_XH_^$K?_ /QJO[$Z
M*/\ B.6+_P"@6/\ X$_\@_UFJ?R+[S^.S_AA[XU?]$?^*/\ X2M__P#&J/\
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MQ-7]R<)?\B/!?]>J?_I$3]-R_P#W6G_A7Y(****^@.L**** "BBB@ K]?/\
M@T+_ .3COC!_V+=I_P"E1K\@Z_7S_@T+_P"3COC!_P!BW:?^E1KX;Q*_Y)K%
M>B_]*B>7G7^Y3^7YH_>BBBBOXT/SL**** "BBB@ HHHH **** /PQ_X/ _\
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MQ?\ P40_X*&>.?\ @I%\?;CQMXRD6SM8$-KHVB6TK-9Z):YSY<>?O.Q^9Y"
M7;L%"JOF?QN^._C+]I+XC7WB[QYXDU7Q5XCU)LSWU_,9),9)"*/NI&N3M1 %
M4<  5R5?TKP/X>X7(8^WJ/VE=JSET2ZJ*_-O5^2T/LLLRF&%7,]9]^WH%%%%
M?HA[ 4444 %%%% !1110 4444 ?T=?\ !JG_ ,HQM0_[';4?_2>SK]*J_-7_
M (-4_P#E&-J'_8[:C_Z3V=?I57\4<>?\E#C/\;/S;-/][J>K"BBBODC@"BBB
M@ K^?O\ X.YO^3U?AK_V)(_]+[JOZ!*_G[_X.YO^3U?AK_V)(_\ 2^ZK].\(
MO^2DI_X9_D>UP_\ [XO1_D?D_1117];'WP4444 %%%% !1110!]"?\$FK:.[
M_P""FOP&66..15\<Z4X#J& 9;E&4_4, 0>Q -?UP5_)'_P $D_\ E)S\!_\
ML=M,_P#2A:_K<K^:?'#_ )&.&_P/_P!*9\9Q-_&AZ?J%%%%?B)\T%%%% !11
M10 5^3W_  =S?\F5_#7_ +'8?^D%U7ZPU^3W_!W-_P F5_#7_L=A_P"D%U7V
MGAW_ ,E)A/\ %^C/2RC_ 'RGZG\_E%%%?V@?HP4444 %%%% !1110 5_9U\"
M=(;P]\#_  ;I[NLCV.AV5NSJ.&*6Z+D?7%?QBU_:1\,_^2;^'_\ L&VW_HI:
M_ O'23]G@UYU/R@?*\4;4_G^AN4445_/!\B%%%% !1110 5\N?\ !:W_ )14
M?'#_ +%N3_T9'7U'7RY_P6M_Y14?'#_L6Y/_ $9'7L<._P#(UPO_ %\A_P"E
M(Z,'_'AZK\S^3ZBBBO[L/U **** "BBB@ HHHH *_J+_ .#=/_E#=\'?^XU_
MZ?-0K^72OZB_^#=/_E#=\'?^XU_Z?-0K\=\;?^1'2_Z^Q_\ 2*A\]Q+_ +K'
M_$OR9]LT445_+I\0%%%% !7P7_P<K_\ *(SQY_V$M(_].$%?>E?!?_!RO_RB
M,\>?]A+2/_3A!7TG!O\ R/L'_P!?8?\ I2.S+_\ >J?^)?F?S'T445_<!^F!
M1110 4444 %%%% !7];G_!)'_E&-\!_^Q)TS_P!)UK^2.OZW/^"2/_*,;X#_
M /8DZ9_Z3K7XCXX?\B[#_P"-_P#I+/F>)OX,/7]#Z(HHHK^:3XT**** "BBB
M@#^8_P#X.5_^4NGCS_L&Z1_Z;X*^"Z^]/^#E?_E+IX\_[!ND?^F^"O@NO[@X
M-_Y$.#_Z]0_])1^F9=_NM/\ PK\@HHHKZ0[ HHHH **** "OT/\ ^#7[_E*O
MI'_8MZI_Z+6OSPK]#_\ @U^_Y2KZ1_V+>J?^BUKY?C;_ )$&,_Z]R_(X<S_W
M2IZ,_I5HHHK^(S\U"BBB@ HHHH ^)O\ @XL_Y0W?&+_N"_\ I\T^OY=*_J+_
M .#BS_E#=\8O^X+_ .GS3Z_ETK^HO!+_ )$=7_K[+_TBF?;\-?[K+_$_R044
M45^Q'T(4444 %%%% !1110!_6#_P12_Y14? _P#[%N/_ -&25]1U\N?\$4O^
M45'P/_[%N/\ ]&25]1U_"?$7_(UQ7_7R?_I3/R_%_P >?J_S"BBBO'.<****
M "BBB@ K\3?^#Q/_ )MU_P"YE_\ <37[95^)O_!XG_S;K_W,O_N)K]!\*_\
MDJ,+_P!O_P#IN9ZV1_[]#Y_DS\3:***_L,_0@HHHH **** "BBB@#MOV:?\
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M<+/EGMT?1_\ !.BHHHKY,X HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*T?\$UM#_P""F7[+]UX7G:VT_P 9:&7O_"VKRC_CQN\#,;D GR9@H1P,XPK
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MJ>(E/&Y2Y13NKCS#,,-@</+%8N:A".K;_K5]DM7T,ZU:%*#G4=DC'_X)B_\
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M %?KY_P:%_\ )QWQ@_[%NT_]*C7Y!U^OG_!H7_R<=\8/^Q;M/_2HU\-XE?\
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MJBV7=0?5]Y;+[-WJOE<VSQ6='#/U?^7^?W!!!':P)'&BQQQJ%1%&U5 X  [
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M^:O_  :I_P#*,;4/^QVU'_TGLZ_2JOXHX\_Y*'&?XV?FV:?[W4]6%%%%?)'
M%%%% !1110!_+C_P7G_8(N/V&?V\M>;3[+R/ _Q"EE\1>'9$3;%$)'S<VH[
MPS,0%'2-X3_%BOBFOZS/^"K?_!.?1?\ @I9^RGJ7@VYDMM/\4Z:QU'PQJLJG
M%A?*I 5R 3Y,H_=R  X!# %D6OY5?BU\)_$7P*^)>N>#_%NDW6A^)/#EV]CJ
M%C<+B2"5#@C(X93P592592&!(()_KSPTXNAG&6QH59?OZ22DNK2T4O.^S\_5
M'Z!DN8+$4>67Q1T?^?\ 74YVBBBOT@]@**** "BBB@#Z(_X))_\ *3GX#_\
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M].2?Y_=N><T445[IU!7Z^?\ !H7_ ,G'?&#_ +%NT_\ 2HU^0=?KY_P:%_\
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M<7_!.WX4_P#!0OX>#0?B1X=BOI[56&FZQ:D0:II#-U:"?!(!."8V#1L0-RG
MQ[A171A,97PM:-?#3<)QU33LU\RZ=24)<T'9H_FA_P""BW_!NO\ &7]BZ2^\
M0>$+>?XJ_#^$M)]NTFV/]IZ?'U_TFT&6P!G,D6],*6;R\XK\^F4HQ5@593@@
M]J_MCKY'_;D_X(D_L_\ [>4EYJ?B'PK_ ,(UXPNLL?$GAQEL;Z1^NZ9=IAG)
MXRTL;/@8#+7[IPSXT3@E0SN'-_?BM?\ MZ.B?K&W^%GT^"XC:]W$J_FOU7^7
MW'\J=%?J#^UQ_P &KWQN^#TUU?\ PRU;0_BKHL99X[9772M611SS%,WDO@<?
M)-N8CA!D"OSL^,7P \=?L\^)#H_CSP?XF\':GD[;;6=-FLI) /XD$BC<O0AE
MR""""0:_;,HXDRO-(\V KQGY)^\O6+M)?-'TF'QE"NKTI)_G]VYR-%%%>X=0
M4444 %%%% !1110 445ZI^S[^PY\8/VJ[F-/AW\-_&'BN&1MGVNRTZ3[%&<X
M^>X8"%/^!.*QQ&)I4(.I7DHQ75M)?>R93C!<TG9'E=%?J]^RM_P:>_%KXAR6
MU]\5O%GA[X=:<QS+I]@?[8U0>JG85MTSTW++)CGY3QG]3/V,O^"'7[.O[$LU
MKJ.A>#(_$_BBUP5U_P 3LNI7B-_>C0J((6'/S11JV"06-?G&>>+&1X!.-"3K
M3[0V^<GI;TYO0\?%9]A:6D7S/RV^_P#RN?A?^P'_ ,$$/CO^W3+8:L^CM\._
M ET5=O$'B"%HC/$>K6UKQ+/D<J?DC;IY@K]WO^"=?_!';X._\$W]'CN?"^DM
MKWC::'R[SQ5JZ++J$F1\R0C&VWB)S\L8R1@.SD U]645^#<4>(V;9TG2G+V=
M+^2.S_Q/>7X+R/E<=G%?$^ZW:/9?KW"BBBO@3RPHHHH **** "BBB@ HHHH
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MODRG_?2$#U-?TKPSXO99C8*EF?[FKW^P_1_9]):+^9GV6"X@HU%RUO=E^'_
M^?WGXYT5[E\=O^"9W[0'[--Q.OC3X1^.=)M[<$R7L6FO>V*XZ_Z3!OA/X/7A
MS*48JP*LIP0>U?JV%QF'Q,/:8>:G'O%IK[T>[3J0FKP::\A****Z"SZ(_P""
M2?\ RDY^ _\ V.VF?^E"U_6Y7\D?_!)/_E)S\!_^QVTS_P!*%K^MROYI\</^
M1CA_\#_]*9\9Q-_&AZ?J%%%%?B)\T%%%% !1110 4444 %?/_P#P47_X)Q^
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M_MA\IQ1M3^?Z&Y1117\\GR04444 %%%% !1110 5XS^W7^PIX#_X*$? :_\
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MR+L/_C?_ *2SYGB;^##U_0^B****_FD^-"BBB@ HHHH **** /RY_P""VO\
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MP !@5Z?117XKB,15KU'6KR<I2U;;NV_-L^;E*4GS2=V%%%%8DA1110 4444
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M110 4444 %%%% !1110 4444 %%%% !1110!S_B[X4>%OB!(KZ]X:\/ZVZC
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M2>N4B4S?E,*_4BBO,QGB9Q)B5RRQ+BO[JC'\4K_B85,ZQD]'.WI9'D/[-7[
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MK3*00U]I\5P1C@??4]B:WJ*J,Y0?-%V8TVM4>6_\,._!7_HC_P +?_"4L/\
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MDMI6'&2K6\L:JQQU*D<GY>F/<J^#.?PCS1=.7DI._P",4OQ.J7#N+2NK??\
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MC@J?MZ]N;J^WH?.?AWPYJ'B_7+72])L+S5-2OI!%;6EI T\]PYZ*B*"S,?0
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M3ACQ!C$[MI_+_(_C)^-/P!\;_LX^,I/#_CWPGX@\(:U&,_9-5LI+61U_O+N
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH _(K_ (+Z?\%D?C7_ ,$\_P!L/PWX+^&]]X=M=#U3P;:Z
MW.M_I274AN9+V^A8AB1A=EO'QZ@GO7P__P 10/[5?_06\$_^$['_ /%5V_\
MP=K_ /*1SP5_V3>Q_P#3GJM?ES7]9<$\)Y-B<BPU?$86$IRBFVXIMN[W9]YE
MN PT\+"4X)MKL?H?_P 10/[5?_06\$_^$['_ /%4?\10/[5?_06\$_\ A.Q_
M_%5^>%%?5?ZDY!_T!T__  %'=_9N$_Y]K[C]#_\ B*!_:K_Z"W@G_P )V/\
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M_P"@.G_X"C3^S<)_S[7W'Z'_ /$4#^U7_P!!;P3_ .$['_\ %4?\10/[5?\
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M_P#06\$_^$['_P#%4?\ $4#^U7_T%O!/_A.Q_P#Q5?GA17]D?ZDY!_T!T_\
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M*#^S<)_S[7W'Z'_\10/[5?\ T%O!/_A.Q_\ Q5'_ !% _M5_]!;P3_X3L?\
M\57YX44?ZDY!_P! =/\ \!0?V;A/^?:^X_0__B*!_:K_ .@MX)_\)V/_ .*H
M_P"(H']JO_H+>"?_  G8_P#XJOSPHH_U)R#_ * Z?_@*#^S<)_S[7W'Z'_\
M$4#^U7_T%O!/_A.Q_P#Q5'_$4#^U7_T%O!/_ (3L?_Q5?GA11_J3D'_0'3_\
M!0?V;A/^?:^X_0__ (B@?VJ_^@MX)_\ "=C_ /BJ/^(H']JO_H+>"?\ PG8_
M_BJ_/"BC_4G(/^@.G_X"@_LW"?\ /M?<?H?_ ,10/[5?_06\$_\ A.Q__%4?
M\10/[5?_ $%O!/\ X3L?_P 57YX44?ZDY!_T!T__  %!_9N$_P"?:^X_0_\
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MT'3?&_AN\TS4[.SU;2-6MWM[JUN(EFM[N&12K(ZME61E)!!R"#7\5-?UO_\
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M%%%%<)F%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?SP_\':__ "D<
M\%?]DWL?_3GJM?ES7ZC?\':__*1SP5_V3>Q_].>JU^7-?VIX?_\ ).X3_ OS
M9^D93_N=/T"BBBOL#T K[T_X-J/^4NG@/_L&ZO\ ^F^>O@NOO3_@VH_Y2Z>
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MBVFNS6C1^:RBXOE>X4445F2%%%% !1110 4444 %%%% !1110 4444 %%%%
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M_P"3<?A__P!BWIW_ *2QU^"^.G\#!^L_RB?*\3_#3^?Z';4445_.I\B%%%%
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MK-4_D7WG\=G_  P]\:O^B/\ Q1_\)6__ /C5'_##WQJ_Z(_\4?\ PE;_ /\
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MWS'P_$&#]G6]M':7Y_\ !_S.LHHHK\?/GPHHHH **** "BBB@ HHHH ****
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M-5_8G17Z]_Q'+%_] L?_  )_Y'T'^LU3^1?>?QV?\,/?&K_HC_Q1_P#"5O\
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M\VS.6#4>6-^:_P"%O\S^0C_AA[XU?]$?^*/_ (2M_P#_ !JC_AA[XU?]$?\
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M %FJ?R+[S^.S_AA[XU?]$?\ BC_X2M__ /&J/^&'OC5_T1_XH_\ A*W_ /\
M&J_L3HH_XCEB_P#H%C_X$_\ (/\ 6:I_(OO/X[/^&'OC5_T1_P"*/_A*W_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !7\Z?_  <\?M[_ /#1G[7MO\*M"O?.\*?"
M/?;W?EOF.[UB0#[03CKY*A80#RKK/CAJ_:C_ (*C_MLVO_!/_P#8G\8_$1FA
M;6H(/[.\/V\@!%UJ<X*0#!^\J'=*X[I"_>OY*=<UR\\3:U>:EJ%U/>ZAJ$[W
M-S<3.7DGE=BSNS'DLS$DD]2:_=/!?AKVV(GG-9>[3]V'^)KWG\D[?]O/L?3\
M.8/FF\3+9:+UZ_A^95HHHK^D#[$***U/ _@O5/B3XUT?P[H=G+J&M:_?0Z=I
M]K$/GN;B:18XXU]V=E ]S4RDHIREHD%[:L_6S_@U%_89'CGXM^)_CUKEFLFF
M^#5?0?#K2#.=1FC!N9E]XK=PGH?M1[KQ^\E>/?L#?LEZ7^P[^R)X'^&>F+ S
M^'=.1=1N8AQ?7\G[RZGYYP\S.5!Y5=J]%%>PU_%/&W$#SG-ZN,3]R_+#_"MO
MOUD_-L_-<RQ?UG$2J=-EZ?UJ?S2_\'(O["W_  R;^WC=^+='L6M_!_Q<637K
M5E7$4.H!@+Z$>_F,DV.@%R .G'YZU_5%_P %ROV&#^W9^P!XFTG2[-KOQEX0
M!\2>'%C&9)KB!&\RW4?Q&:%I8PO3>8R?NU_*[7])>%_$?]J9-&%1WJ4?<EW:
M7POYK3S:9]EDF,]OADGO'1_H%%%%?HQ[ 5^Z'_!J'^W@WB3P;XF_9]UZ[+7'
MA]9/$7A@R-UM7D47=LN?[DSK*JC)/GS'HM?A?7IG[''[4&N?L9?M.^#/B;X>
M9FU#PGJ*730;]BWMN<I/;L>RRPM)&3V#Y'(KY?C+A^.<Y35P7VK7@^TEM]^S
M\FSAS'"+$T)4^O3U_K0_L8HKG/A!\5M$^.GPK\.>-/#=T+[0/%6FP:KI\^,%
MX9HPZ9'\+ -@J>000>171U_$M2G*$G":LUHUV9^;--.S"BBBI$%%%% !1110
M 4444 %%%% !1110 4444 %%%% !7RY_P6M_Y14?'#_L6Y/_ $9'7U'7RY_P
M6M_Y14?'#_L6Y/\ T9'7L<._\C7"_P#7R'_I2.C!_P >'JOS/Y/J***_NP_4
M HHHH *_KX_X)I?\HX_V?_\ LF_AW_TV6U?R#U_7Q_P32_Y1Q_L__P#9-_#O
M_ILMJ_#?'+_<<+_CE^1\SQ-_"AZO\CVRBBBOYM/C0HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OSO_
M .#H+_E%3JW_ &,FE_\ HQZ_1"OSO_X.@O\ E%3JW_8R:7_Z,>OJ."?^1_@_
M^OD?S.[+?]ZI^J/YJZ***_MP_2@HHHH *_M(^&?_ "3?P_\ ]@VV_P#12U_%
MO7]I'PS_ .2;^'_^P;;?^BEK\!\=/@P7K4_]L/E.*-J?S_0W****_GD^2"BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OB;_@XL_Y0W?&+
M_N"_^GS3Z^V:^)O^#BS_ )0W?&+_ +@O_I\T^OH.$O\ D>8+_K[3_P#2XG7E
M_P#O5/\ Q+\T?RZ4445_<A^FA1110 5_9=^S1_R;C\/_ /L6]._])8Z_C1K^
MR[]FC_DW'X?_ /8MZ=_Z2QU^"^.G\#!^L_RB?*\3_#3^?Z';4445_.I\B%%%
M% !1110 4444 %%%% !1110 4444 %%%% !7\K/_  7K_P"4N?QI_P"PE:?^
MF^UK^J:OY6?^"]?_ "ES^-/_ &$K3_TWVM?LW@C_ ,CFM_UZ?_I<#Z+AK_>9
M?X?U1\@T445_3Q]L%%%% 'Z^?\&A?_)QWQ@_[%NT_P#2HU^]%?@O_P &A?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M5_V))_\ 2^UK\GZ_6#_@T9_Y/5^)7_8DG_TOM:^*\1?^2;Q?^%?^E(\W./\
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M>[,Q))]35&O[AX>R6EE.74L!1V@K-]WNW\W=GZ;@\/&A1C2CT_/J%%%%>T=
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M4N?QI_["5I_Z;[6OZIJ_E9_X+U_\I<_C3_V$K3_TWVM?LW@C_P CFM_UZ?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@#^>'_@[7_Y2.>"O^R;V/\ Z<]5K\N:
M_4;_ (.U_P#E(YX*_P"R;V/_ *<]5K\N:_M3P_\ ^2=PG^!?FS](RG_<Z?H%
M%%%?8'H!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !7]8/_!%+_E%1\#_^Q;C_ /1DE?R?5_6#_P $4O\ E%1\#_\
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M]#<HHHK^>3Y(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*^)O^#BS_E#=\8O^X+_Z?-/K[9KXF_X.+/\ E#=\8O\ N"_^GS3Z^@X2_P"1
MY@O^OM/_ -+B=>7_ .]4_P#$OS1_+I1117]R'Z:%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'Z^?\&A?_)QW
MQ@_[%NT_]*C7[T5^"_\ P:%_\G'?&#_L6[3_ -*C7[T5_(GBU_R4M;TA_P"D
MH_/\^_WV7R_(****_-CQPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#^>'_@[7_P"4
MCG@K_LF]C_Z<]5K\N:_4;_@[7_Y2.>"O^R;V/_ISU6ORYK^U/#__ ))W"?X%
M^;/TC*?]SI^@4445]@>@%%%=M^SY^SKXT_:J^*-EX+^'^@W'B3Q1J,<LMM80
MRQQ/*L2&20AI&5>%4GD]JSK5H4H.K5:C%*[;=DDMVV]D3*2BN:6QQ-%?7W_#
MA/\ :Z_Z(MKG_@RT_P#^/T?\.$_VNO\ HBVN?^#+3_\ X_7C_P"M&3?]!=+_
M ,&0_P SG^O8?_GY'[T?(-%?7W_#A/\ :Z_Z(MKG_@RT_P#^/T?\.$_VNO\
MHBVN?^#+3_\ X_1_K1DW_072_P#!D/\ ,/KV'_Y^1^]'R#17U]_PX3_:Z_Z(
MMKG_ (,M/_\ C]'_  X3_:Z_Z(MKG_@RT_\ ^/T?ZT9-_P!!=+_P9#_,/KV'
M_P"?D?O1\@T5]??\.$_VNO\ HBVN?^#+3_\ X_1_PX3_ &NO^B+:Y_X,M/\
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M+:Y_X,M/_P#C]'_#A/\ :Z_Z(MKG_@RT_P#^/T?ZT9-_T%TO_!D/\P^O8?\
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MC_6W(_\ H-I?^#(?_)!_:&%_Y^1^]?YGQ-17VS_Q#I_MD?\ 1'?_ "Z]#_\
MDRC_ (AT_P!LC_HCO_EUZ'_\F4?ZVY'_ -!M+_P9#_Y(/[0PO_/R/WK_ #/B
M:NV_9I_Y.-^'_P#V,FG?^E4=?4?_ !#I_MD?]$=_\NO0_P#Y,KJ?@?\ \&^W
M[7G@_P"-7@_5M2^$?V?3]+UNRO+J7_A*=%?RHHYT=VVK>$G"@G !)["N?%<6
M9(Z,TL92V?\ R\AV]29X_#<K_>1^]?YG],5%%%?Q&?F@4444 %%%% !1110
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M?_\ LF_AW_TV6U?AOCE_N.%_QR_(^9XF_A0]7^1[91117\VGQH4444 %%%%
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M6US_ ,&6G_\ Q^N'_6C)O^@NE_X,A_F8_7L/_P _(_>CY!HKZ^_X<)_M=?\
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M%M<_\&6G_P#Q^C_APG^UU_T1;7/_  9:?_\ 'Z/]:,F_Z"Z7_@R'^8?7L/\
M\_(_>CY!HKZ^_P"'"?[77_1%M<_\&6G_ /Q^C_APG^UU_P!$6US_ ,&6G_\
MQ^C_ %HR;_H+I?\ @R'^8?7L/_S\C]Z/D&BOK[_APG^UU_T1;7/_  9:?_\
M'Z^:_C7\%/%'[.GQ1U?P7XTTB;0?%&@R+%?V$LB2/;LR+(H+(S*<JZG@GK75
M@\XP&+FZ>%KPJ22O:,HR=N]DWH:4\12J.U.2;\FF<K1117I&P4444 ?KY_P:
M%_\ )QWQ@_[%NT_]*C7[T5^"_P#P:%_\G'?&#_L6[3_TJ-?O17\B>+7_ "4M
M;TA_Z2C\_P ^_P!]E\OR"BBBOS8\<**** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _GA
M_P"#M?\ Y2.>"O\ LF]C_P"G/5:_+FOU&_X.U_\ E(YX*_[)O8_^G/5:_+FO
M[4\/_P#DG<)_@7YL_2,I_P!SI^@4445]@>@%?>G_  ;4?\I=/ ?_ &#=7_\
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M_BE_X([?_P"2:/\ B*L_9C_Z!_Q2_P#!';__ "37\XM%'_$'.'O[_P#X%_P
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M]C)I?_HQZ^HX)_Y'^#_Z^1_,[LM_WJGZH_FKHHHK^W#]*"BBB@ K^TCX9_\
M)-_#_P#V#;;_ -%+7\6]?VD?#/\ Y)OX?_[!MM_Z*6OP'QT^#!>M3_VP^4XH
MVI_/]#<HHHK^>3Y(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *^)O^#BS_E#=\8O^X+_Z?-/K[9KXF_X.+/\ E#=\8O\ N"_^GS3Z^@X2
M_P"1Y@O^OM/_ -+B=>7_ .]4_P#$OS1_+I1117]R'Z:%%%% !7]EW[-'_)N/
MP_\ ^Q;T[_TECK^-&O[+OV:/^3<?A_\ ]BWIW_I+'7X+XZ?P,'ZS_*)\KQ/\
M-/Y_H=M1117\ZGR(4444 %%%% !1110 4444 %%%% !1110 4444 %?RL_\
M!>O_ )2Y_&G_ +"5I_Z;[6OZIJ_E9_X+U_\ *7/XT_\ 82M/_3?:U^S>"/\
MR.:W_7I_^EP/HN&O]YE_A_5'R#1117]/'VP4444 ?KY_P:%_\G'?&#_L6[3_
M -*C7[T5^"__  :%_P#)QWQ@_P"Q;M/_ $J-?O17\B>+7_)2UO2'_I*/S_/O
M]]E\OR"BBBOS8\<**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%%%% !7]8/\ P12_Y14? _\ [%N/_P!&25_)]7]8/_!%+_E%1\#_ /L6X_\
MT9)7XKXW_P#(JH?]?/\ VV1\WQ-_ CZ_HSZCHHHK^93XL**** "BBB@ HHHH
M **** "BBB@#^8__ (.5_P#E+IX\_P"P;I'_ *;X*^"Z^]/^#E?_ )2Z>//^
MP;I'_IO@KX+K^X.#?^1#@_\ KU#_ -)1^F9=_NM/_"OR"BBBOI#L"OU@_P"#
M1G_D]7XE?]B2?_2^UK\GZ_6#_@T9_P"3U?B5_P!B2?\ TOM:^*\1?^2;Q?\
MA7_I2/-SC_<ZGI^I_0)1117\8'YR%%%% !1110 4444 %%%% !1110 4444
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M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?G?\ \'07_**G5O\
ML9-+_P#1CU^B%?G?_P '07_**G5O^QDTO_T8]?4<$_\ (_P?_7R/YG=EO^]4
M_5'\U=%%%?VX?I04444 %?VD?#/_ ))OX?\ ^P;;?^BEK^+>O[2/AG_R3?P_
M_P!@VV_]%+7X#XZ?!@O6I_[8?*<4;4_G^AN4445_/)\D%%%% !1110 4444
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M *5&OWHK^1/%K_DI:WI#_P!)1^?Y]_OLOE^04445^;'CA1110 4444 %%%%
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M.0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#/4/_DBC_APE^R+_ -$6T3_P9ZA_\D5^;_\ $;LF_P"?-7[H?_)GC_ZRX?\
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M&#]9_E$^5XG^&G\_T.VHHHK^=3Y$**** "BBB@ HHHH **** "BBB@ HHHH
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M':__ "D<\%?]DWL?_3GJM?ES7ZC?\':__*1SP5_V3>Q_].>JU^7-?VIX?_\
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M!\$__"YTS_X_1_P\M_9Q_P"C@/@G_P"%SIG_ ,?K^0>BC_B!V!_Z"9_=$/\
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M'[/OP/T+]FKX(>%? /AFW%MH7A'3(=,M%Q\SK&H!D?U=VR['J69B>37XP?\
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M44 %%%% !7RY_P %K?\ E%1\</\ L6Y/_1D=?4=?+G_!:W_E%1\</^Q;D_\
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M,?11_P 05R'^>K_X%'_Y /\ 5O"]Y?>O\C^G#_B)7_9%_P"A\US_ ,)G4/\
MXU1_Q$K_ +(O_0^:Y_X3.H?_ !JOYCZ*/^(*Y#_/5_\  H__ " ?ZMX7O+[U
M_D?TX?\ $2O^R+_T/FN?^$SJ'_QJC_B)7_9%_P"A\US_ ,)G4/\ XU7\Q]%'
M_$%<A_GJ_P#@4?\ Y /]6\+WE]Z_R/Z</^(E?]D7_H?-<_\ "9U#_P"-4?\
M$2O^R+_T/FN?^$SJ'_QJOYCZ*/\ B"N0_P ]7_P*/_R ?ZMX7O+[U_D?TX?\
M1*_[(O\ T/FN?^$SJ'_QJC_B)7_9%_Z'S7/_  F=0_\ C5?S'T4?\05R'^>K
M_P"!1_\ D _U;PO>7WK_ "/Z</\ B)7_ &1?^A\US_PF=0_^-4?\1*_[(O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 ?SP_P#!VO\ \I'/!7_9-['_ -.>JU^7-?J-_P ':_\ RD<\
M%?\ 9-['_P!.>JU^7-?VIX?_ /).X3_ OS9^D93_ +G3] HHHK[ ] *^]/\
M@VH_Y2Z> _\ L&ZO_P"F^>O@NOO3_@VH_P"4NG@/_L&ZO_Z;YZ^;XR_Y$.,_
MZ]3_ /26<>8_[K4_PO\ (_IPHHHK^'S\S"BBB@ HHHH **** "BBB@ HHHH
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M_7J'_I*/TS+O]UI_X5^04445](=@4444 %%%% !1110 4444 %%%% !1110
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M3Q:_Y*6MZ0_])1^?Y]_OLOE^04445^;'CA1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M '\\/_!VO_RD<\%?]DWL?_3GJM?ES7[W?\%]?V'?"?[2_P"V'X;U[7M0\16E
MY:>#;6P1+">&.,QK>WS@D/$YW9D;OC ''K\/_P##I;X<_P#0:\;?^!EK_P#(
M]?V!P+FU&GD&%IR3NH+MW?F?H.5XB*PL$^Q^>-%?H=_PZ6^'/_0:\;?^!EK_
M /(]'_#I;X<_]!KQM_X&6O\ \CU]9_;=#L_P_P SO^LQ\S\\:^]/^#:C_E+I
MX#_[!NK_ /IOGK:_X=+?#G_H->-O_ RU_P#D>OJC_@C'_P $^_!OP"_X* >%
M?$VCZGXGN;^SL]0C2.\N('A(>TE0Y"PJ>A..>M?/<6YO1GDF+@D[NG-=/Y7Y
MG'F&(B\-47D_R/VNHHHK^-#\["BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ KQ/\ X*6_\HX_V@/^R;^(O_39<U[97FO[9_A*W\?_ +'GQ8T&\>>.SUKP
M;J]A.\)"R)'+93(Q4D$!@&.,@C/8UWY5+EQM%O\ GC^:-:&E2+\T?QRT5^AW
M_#I;X<_]!KQM_P"!EK_\CT?\.EOAS_T&O&W_ (&6O_R/7]N_VW0[/\/\S]+^
MLQ\S\\:*_0[_ (=+?#G_ *#7C;_P,M?_ )'H_P"'2WPY_P"@UXV_\#+7_P"1
MZ/[;H=G^'^8?68^9^>-?U@_\$4O^45'P/_[%N/\ ]&25^)G_  Z6^'/_ $&O
M&W_@9:__ "/7[S?\$U_AW9?";]A/X8^&]-ENIK'1]&2WA>Y96E90[GYBJJ">
M>P%?C_C+F%/$990C!/2IU_PR\SY[B*LIT8I=_P!#W"BBBOYS/D HHHH ****
M "BBB@ HHHH **** /YC_P#@Y7_Y2Z>//^P;I'_IO@KX+K]MO^"SG_!/OP;\
M??\ @H!XJ\3:QJ?B>VO[RST^-X[.X@2$!+2)!@-"QZ 9YZU\K_\ #I;X<_\
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M.64KJ%N>5^KU4?NL_O78^7XBQCDXT8[;O] HHHK\*/EPHHHH **** "BBB@
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MWPY_Z#7C;_P,M?\ Y'H_MNAV?X?YA]9CYGYXT5^AW_#I;X<_]!KQM_X&6O\
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MO_R/7]C_ -MT.S_#_,_1/K,?,_/&BOT._P"'2WPY_P"@UXV_\#+7_P"1Z/\
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-44 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>strm-20221024.xsd
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.16b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaeKWbP9z5Z8KekhvWB6bQk6jyAtZta4KiOrmrIG4U0L -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap="http://fasb.org/srt-sup/2022q3" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:STRM="http://streamlinehealth.net/20221024" elementFormDefault="qualified" targetNamespace="http://streamlinehealth.net/20221024">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://streamlinehealth.net/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="strm-20221024_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="strm-20221024_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap-sup/2022q3" schemaLocation="https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd" />
    <import namespace="http://fasb.org/srt-sup/2022q3" schemaLocation="https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd" />
    <import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
    <import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
    <import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>strm-20221024_lab.xml
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.16b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>strm-20221024_pre.xml
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.16b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://streamlinehealth.net/role/Cover" xlink:href="strm-20221024.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://streamlinehealth.net/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139892192614656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Oct. 24, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Oct. 24,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-28132<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Streamline
Health Solutions, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001008586<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">31-1455414<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2400
Old Milton Pkwy.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Box 1353<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Alpharetta<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">GA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">30009<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(888)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">997-8732<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, $0.01 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">STRM<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="strm-20221024.xsd" xlink:type="simple"/>
    <context id="From2022-10-24to2022-10-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001008586</identifier>
        </entity>
        <period>
            <startDate>2022-10-24</startDate>
            <endDate>2022-10-24</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-10-24to2022-10-24">0001008586</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-10-24to2022-10-24">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2022-10-24to2022-10-24">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2022-10-24to2022-10-24">2022-10-24</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2022-10-24to2022-10-24">Streamline Health Solutions, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-10-24to2022-10-24">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2022-10-24to2022-10-24">0-28132</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-10-24to2022-10-24">31-1455414</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-10-24to2022-10-24">2400 Old Milton Pkwy.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2022-10-24to2022-10-24">Box 1353</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2022-10-24to2022-10-24">Alpharetta</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-10-24to2022-10-24">GA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2022-10-24to2022-10-24">30009</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-10-24to2022-10-24">(888)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-10-24to2022-10-24">997-8732</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2022-10-24to2022-10-24">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2022-10-24to2022-10-24">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2022-10-24to2022-10-24">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2022-10-24to2022-10-24">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2022-10-24to2022-10-24">Common     Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-10-24to2022-10-24">STRM</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-10-24to2022-10-24">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-10-24to2022-10-24">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>13
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M;%!+ 0(4 Q0    ( -R"6U6B:^:M[0   "L"   1              "  :\
M  !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( -R"6U697)PC$ 8  )PG
M   3              "  <L!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#
M%     @ W();5?YXP?-D!   )A$  !@              ("!# @  'AL+W=O
M<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( -R"6U6?H!OPL0(  .(,
M   -              "  :8,  !X;"]S='EL97,N>&UL4$L! A0#%     @
MW();59>*NQS     $P(   L              ( !@@\  %]R96QS+RYR96QS
M4$L! A0#%     @ W();5:K$(A8S 0  (@(   \              ( !:Q
M 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( -R"6U4D'INBK0   /@!   :
M              "  <L1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+
M 0(4 Q0    ( -R"6U5ED'F2&0$  ,\#   3              "  ; 2  !;
H0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  /H3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://streamlinehealth.net/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="form8-k.htm">form8-k.htm</File>
    <File>ex10-1.htm</File>
    <File>ex5-1.htm</File>
    <File>ex99-1.htm</File>
    <File>ex99-2.htm</File>
    <File>strm-20221024.xsd</File>
    <File>strm-20221024_lab.xml</File>
    <File>strm-20221024_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "form8-k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "strm-20221024_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "strm-20221024_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "strm-20221024.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "STRM",
   "nsuri": "http://streamlinehealth.net/20221024",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form8-k.htm",
      "contextRef": "From2022-10-24to2022-10-24",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://streamlinehealth.net/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form8-k.htm",
      "contextRef": "From2022-10-24to2022-10-24",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001493152-22-029722-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-22-029722-xbrl.zip
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M&Z#$)!6YA'R7)A^ I[MP "BFOWP"U@^'_9Y)M &.O%;A6 &@=/#&'#:8/4A
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M%>/V>YC'D%4IA4TDR2,4JQ0B@9>;)''([#;P5PT&\U8KMXMXQ:)P\J<N^LS
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M>02Z-+].<24,C^=3L' >UW6QHX_UT<=C!/)7*#.0-14&'--V[&UW2ZWVN]Y
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M;\_$H2S*KBC87R@*MM:F2^MHE_33J^/]WTF'?GOV[O#E_P=02P,$%     @
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M@%_CQ-@DM=C&B7?MV %FM^:C4 M0+%H=26W,_/H]5^INL!TGFYW)9-E*JF)
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M>;&KLP59E&)9$>8623-*[)N924'QGP-IM^BZ;KR_2]=\_PU02P,$%     @
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M-VQR>13I-^D?:7+_:A/]XT[_ U!+ P04    " #<@EM5J*FF7<DA   AZ
M"P   &9O<FTX+6LN:'1M[7UI5QNYTO!WSN$_Z.69N0?.@XTW]H3G&##$"5ML
MDV3NEQRY6\8*[6ZG%[#SZ]^JDM2+%R 90X!X[IT!NK54E4JEVE3]YO\&/8?=
M"#^0GOMVJ9@O+#'A6IXMW:NW2U'8R6TM_=_>XL*;;@CMH*T;O%WJAF%_9VWM
M]O8V?UO.>_[56G%[>WMM@&V65*.=P<1VI4*AN/;E]*1I=46/YZ0;A-RU1-S)
MD>[U]/'Q;=RT[3LRTQ2?F$G*:V-#PUL[Z9!NO+&F7F::AA.;KJNFH6DJ Z]2
M*F[>!8=J$7<83&M;1)@!0_%EOW&2- \GMT^:KH4^=X..Y_=X"&N((ZWG"J5<
M:2,U2"X05F8@^#M_Y=W<.\Y6KEPTXXPM3A93?-WF04QQ6XR0V\P)+Z!'J60:
M^J(S==B--7AK&D9![HKS?MRXPX,V-=0O,J/J9[D@ZO<=T1-N.+4?MJ&^W\NF
M=^"'=_;4[T=ZP7B^YXA@XDST)@.BY45NZ \G4TF_S'2 62>"DFG4;#5.XU9!
MZ O>PS7N"NZ$W;PK5.MBH519HHTMN T_&?[S)I2A(_;>K*F?\+8G0LYPK)SX
M'LF;MTL'GAL"17*M81]6VE)_O5T*Q2!<4_M_#?NMZ6'?_+]<CAU)X=@[K"G"
M77;&>V*'#>S!+JL?TB]?"Z7]KY?-OTN'Q]7J!?Q \%@N]]#>Y<VOB/+72:A^
M-:C^Q'B5P[C7KW1?/_PJ@,,!#_A_S05*#@^ 1#YWZJXM!A_$\&L!I&"AL+6^
MM?$SXVZGQJT"5]K(F4<.O_K:X4X@?F*H#:3WX=?B5RV<U)CPZ&?&*'UM=KDO
M@J^EKR2+U2 !/?N9<0X1E@L]5GD,I*F#MSU[R()PZ(BW2QU@PQU6+/1#UI(]
M:'(F;EG#ZW%W53U8!0!\V2&&M^6-Z6?+H._PX0YS/5?02SG80<X5/FX)^DO:
MMG!I@^"?T/ LZL%8EN+]0=A Z77D>SWDE5RQD"M50B_Y?8FY@#5,)>3.1&Y8
MVDO8X<U:9HK9S)KAE:4]8I:)$ZUET,5Y0?8*']0!$:@6*.)W CJ[ 0!&!_).
ME^0W[+Y>SFR7_""PE_3K$ 0%O)8]D*5*..BILH.KZ0(O\LULT(S6?D>CS*1]
M)\I&B)EN@J@=/XV?2QO?=*3P&:$B)AZ,!_4/V949[9Q,MS9Q/CU;'^CKV>-0
M@';BAX<\%'L)"F:DY-U8-UC**9W,FU&P,@"8AYJD63I'KE1$AFTW1LV>X$'D
MBSV]/W>@C1G,O,I.@:--&5]M]JE3:")0HU^>(Q$J8_.  (!E'*<M]J4-P4//
M3[W^>1J,PCAIU-2DA\+U>M*];]K[Z3(Z[Z2!S?L,%<8(JG=H:C\J\6!DXYLU
MZ \_\7]O^C\KAW=9C_M7TMUAV#3^=Y<A4^:X(Z_@E04;2OA+>V^"/G?3,^0Z
MO"<=D-KWS$%M _E#*)!@I/;>?_ZGN%'8?;/6!B4'QX4?_;V7AL0D\%-G;2-R
M1.Z"7Y%*D#[N;J4==G&<PM]+F1=MSX=ES85>?X?M.]RZ9A5 )? <:>\R_;+M
MA:'7,^^+^?6D11I&!-$0&5E$_S<%WEH&OG]'>P4R-(\?&##IV4MDI]^%TI9&
MZ?*LWJH=+BXT6]56K?FJ4&O6#BX;]5:]UEQ<J)X=LMJ7@W?5L^,:.S@_/:TW
MF_7SLU>!;TGC^YD'7>E>A9Z[NKAPF#_(LU)AO;+]NW$TF^9I!._/"$B-@2,Z
M  B/0B]&RI=7W?B9EJ.E]7O%:$9,CH/WQXI.@^8+WVA&L!R=-TX!?AH2E4^T
M;+<+^V2PYW*'GA6A_84NDZ]6[%M(O P__,-]=[OFW7YNE6&\?VOPI>=;VMO*
M?1BU]F*ZOP)99TYBD.R-VEEK<:%1NSAOM%X5;A>1'T3<#1<70@_:6>B?9<4R
M\WQ67%^V5YC78:VN>%4X YJ1+T,I@L6%VL#J<A>$7M4*$=?B=KGR>I!]);*0
M<$$/Q.("+%%#]#T_9,OX )=,<# O11 R<0.3,I]>"WMEAZ$]<X_@O" 71DTY
M."9+T-N&N.Q_ZIUL1MN_+$%5[./MDAR$.S;,U(-^79L/AP"\<"=)V Q@2WOG
M5NBUA<]*E56& _\)<O<56D"C[%C4[*C<MPUQ)0.,E87HSI[,C6+3OH[L>F6_
MVI[!>3YIWJ6]9ASN6%QX1P$/UO2<",\&0*_N6OE7SW[+M0&WX%1$4J&0\6,2
M,1ZPH"\L]-3:3,)JA@&#0P1DCK_R.I"??&R$O.T(F,UQX+E%0?S"$OW=Y[9M
M_OYI?%.>H]@A9'F.P_L! &1^4Y[6-Z'_*W$9%7^T?QZV&^&'TN*.(34L2@QP
MN?3W4_CC1@3&9D9@P%;T?#CN**S>#.&D.%"AW0//GB(_JM\KVT[4;VUL7<_B
M-,/H/P850M'WO1O<+=GC[ %PPM$N''X+!^%#I$IHSW)!U:9*S.Z_'W$;S1;R
MW\^*AQE6/)*.@'4#'64RWVW\. LJWWM>)+HS.[>2.9?VH,56L?P@O6C.0L^%
MA<H9%FKQ05W'0"V2%'?QTTFQ_H-;T5;QW=;,^&D* $M[Y6*N6%E?KQ0K#^0O
M^(__?$ZLB>L:JR89A6-<W9BI5D6R'YT+7M@%:^8;V.&!+<GKD%$WV(S_^2W8
M@MHHTP=?6CM\'"GTLD3/\V'+ Z_7DT'P*KD0#TFF!-F< 9\K ];SC7PSSVJ]
MON,-A?_ZN#![KK(S+S_&C,F9N4:FYMZ+M9]?E^_J8<I;U;9]$03ZQXET17&R
MXO;>OG:/3]XUOI]\FYGB-F'RI;U2I5!87#AW;'8JG1"8[N+Z=CC-<[7*1M&K
MW(->:3)ZWTXW;KX?5H/U8>41T2LM[>U[ U8LKY=?O2MN NM5)ZW- ?QZ[K>\
M6W?*RM3K ]X<''[<^G4__I252:9>VJLZ?4RC"T,^C=7&P[GKD_ A7?G<O_"]
M&U CIP4GY%;K\L*Y_'%NSQJID?F7]HZK4S :VSL'D_"Y\(*0._^5_>G.*:_;
MZWP\#ZTC:Q;!ZNFS@T57*!2V7_W66=;(4]RL[\,RRCYWF!@(*PKE#7JVX4@6
MP0I;!LHP),VK=F&_3%R2\,Q__F>K5-S<A?4,A2/Z7<\5S"75?A5-32="-SP#
MZ<-AN]AB8@2TH/<FRJPJM)R^&TO!N_W&^V_5^I=9R);T?,"96UM;*P\5)R9H
M>^*!!G^!6-_E&?*C_T8%\>G3]]NK&8 ].N?2WO;V9FYK\V&NQA?-=S/>0W?F
MU'V+ C /AK,$_Z KK&O8*5W!>+_O>R#_T/G4!KVI+1SOELD.PY='GM]C6[D/
MK",=W#XR@+T4"M<6-IB)+)"]R FY*[PH<(8L  ,FZ RII^[@M0$'9==X:LA4
MM#""<?S%!>X.S<N.Y\#LV!%#)A*]#L'.DU)9/Y0N&F70(;\NW7G\\"=<!__*
M1:L!?FRJ_SM_20QD:<903I/MGWT9PJ9#3USD:C=!,%G #S^T!X=7-[WZV:^'
MDM().6W/<P1WZ?9:6O1/! GIO+U9J>Q.%?\SH?\CRT:-VN*"E4&.]74Z( H^
M3 AFE=*Z$F$DNI+,.<J76RYNLH.C!BN5"WEHN#*K",BL]]PSW67/%*Q'9[YQ
M6.?,\J1@&8!&1/&&%L5-SY$6['+WZA04)M":G,ER>+,FK<O-T/ORSGE4.3P.
MS_U"^%EO@ 2AQ86>1FE<]!8K/%<LI:1O)E<YEKV50EZUG(O?5P'67/P^QU5Y
M O&[K<7OA2]0Y<3R!735!BU1_[S3F>;OV-K>:!>MCY=^<3;YZ=/$\'2X7K@X
M!L1R5@JS^[7B8L7.E9;;*P\3SJKM7#R_"K#FXODYKLJX7Z$V69K6@R 2_KTR
M]=V7_G[4XP>'Y=)3RM0QZ/X\R5H6N<JR]3#)JMM.D:PSR"+).E.+TGV(.S7W
M1/[4%^.(3]^W5)YQX0L[L_;QS5,Z5;6C'-;[T?SB<W?W@Y./'U:D908IZ)6G
M2$%O8?E!A2/=';6ZS')X$,SPAH!>WYAB1*OG=W'@J=:UN/4DZ^ISFQPJB&5S
MV&M[SGQ)'VM)*T^R5?$R:G:G"J,*P%%QVY7P)#E/7N 5C,=,D3/>!'WX#HNE
M-HF^R?INY%0BV[_><LNS2/48G7-I#Y5<S]6;,_2LZU7V5R%?*,+&\MD-=Z+?
M=O?OF1HTSX6-CC0;:?&J!.MD'FKP<G=_^^!]Z5#.@(<R$X(.V6J<SEGD^;#(
M&*.LC\@;8[5-KV1P\>U3[:SP_KI3__5,Z=&;R'A C%]"G@33$APO@<V_3V$J
MM2H'O"]#[K!3[E^+\-Z[?C.W.!_?-GOAIF7=M=&7 &I">\@L3/A"0*Y!.1!T
MP7 D&4L&#"86L-)7F']UY7NW(>C_7J^/^5D\8+;H2%>5=5#I#X5U8XV.Y#ZH
M6D%EMHP4W-RE%(C".B7:AEU)%2'Z6!$"+SLJST:IG2M-&&Q2!:)X5/1R)/U2
MP^9?[)(]*L=51ETT5%SOL?/=:IJA%A=&.&J:4U)EIIMNQ]3I0/69+"NW6Y>1
M?5FLM0N/F_)T!V /3GR:,^33BL .9I=.$VJ8%ZY$),M*2#F6J=H%^2<<884@
M_UR/W')1(*@58*#S8?%#'I)<=:KX-W(5S>4,:0/<2I@;6=\%!."5+VYD !U!
MK'+7PCP';M'G)Q!4_(R*S7T[4)FP]C2G8'F9QT[!M+C,LY@E7ZJ7\#E"^LCU
MGS/^B(D>BU2%Z#1P3UO$]*E9(4MHQ&$7!O@>8>P$.BJ$R%08I^X=#I^1:P,;
MM,");SKMBQ[U56?G&'<RCSBCQ_DH<;S<:ZE@75SL84]D*$,PHVT;3=N4BA\C
MBR_X=:XM0#@!-'VB9?I"A:+"R#UH6O!T">',Z&DN>YD,]D(C$H^8@+\YZ]SV
M]EX]%#T%6C%?*,[0-?'(6@2 7L."7 I"Z<+QRYE)MV2':!9)NC%8O?(%Q7+S
MO]T._CW76%XT2N?NXL)H*5%H'==[9)/+/;)E5+WP]F&IL*OM ?JKN+O"R,=$
M-C,P#>AOH)^!VL@-GP1L&64 ZG(WP@&%-#74A6Z]N!"S51"/2ZJD&<\/R$JQ
ML;<OP#Q?GC",'W=>S2B2*E2 '0Z,J8_3T?4NB2D7H+'"E@1!N+@ 0_-45('9
MTA=DF'> I'BY$MY?0>\K77UV8[6TO;VZO;7-]">DX)E%WFY8,')TQRYNX_+&
MKP-AVU&J8A]RCL=8@&8? C@Q4?M@;]&L?Q7SY=*4D<XUJ&:4/!9P1K,@(#W;
M L0#Q#Q-CP[8C?3@/,;31[6_3^8 %8=NZVMT XDIR\Z0_;65+S-@0P=U=-X!
M<C'0X".+5'L![(SM[(1R.)H; (7Z?$@G47N8AD&!:0!2-_""M!%B8-<^EA2L
M:(-<"5?X(*I,O26!5.M[,)\:.&YL.1X:) !SO!$VU$9X6I_*7'K]-$JPCHL+
MR39+;QEV"[M5\=J(%<F1<;!@:Q@%+/GN(K.).\>%(8J"3!_5L"GZ<+1CTV(9
M]J5JJP2+1);VR7G'8X.:+%<JC$FSP1]TS[29*[/E1KK-F9=GY7(Y5]K8+&YM
MK@!GPYZ_)5^DY7#$1@!6)#W-CDDGU""XL4V<U+'*2(1F[2"6JDBP-"J*\UD5
M-DX_OJ+J@'ASF->'0U]=:FWY7A3"$K$+T4>I\PY7$&NJ-#GF:0$<)R<7JX"\
MPVG[:_$"8D_:,HS'U6M',I><K.EMO(J$[$@'WG!TBW9E6X9L/5]4H\'+@\CW
MD9BZ KBA*=[=13)( $/UIZ,C_@@<]%_5#1B>'NUAJBX;M(:_D[9XBJDS*K-*
M3;.2<R'QS%$:$1+ILS@K)-3)#@>99M9$BR#^ 89'.0 6M=K!8/.YX:K*2[R%
MW8<U%]J^=PV[P<.3CSO"S[,#L%4X,+8:W//U#E5U-OS ;(18#T%AT\%[Y,2)
M])T_# J@3]>7[0@?CIRZI?QZ?.IJR,T.FO/F,T>)>-/P66)*J?5&MK$ #AC)
M1XG4!PZ&EUSKX;?<1S>MQ/&);9+>645*O4Y&0FQZ;E)[C?@1U6A0I.+*!1,Y
M,[LKE!Z%+I4KC[RW48_&UQTGH04"]WL$)$Z72D<>]P6<"1KJ3H1J-WV%<_I(
MJ[IR DA[:!0?NTK:HTQ7?N?DV"@6X-P@F9^6]-IV2 O\/*M37-#U0E3^D[H/
MVB5-SFQ5K;3#01^ <U&Z\:>L&6^CG!A38^]8/;4ZWHUP>6KED^-PDDVD!%>/
MVYCY!$( %5ZCWMY%?TYO=;5ZBS09A 4'"SQ'Z)&P=QO4YXZ,EP#U&80U]%0!
MC8F# QX]/D3#((C:W]!* K(YLB<UUL;*BOJ>:U:;!!M7-H*>9"ZUGCE*&:?!
MNM&3T\)"*W2H-@NP,D$-%.0#<%TO<BU2"#.*'H^US7@K\S#D5E?O453;D[V\
MO:WV,N[/>S;SBXWBS3VVO]]C6\H7UE^4Q_; "\) 05@- L]22B0=A;4!"G.?
M'<H 3@DXM*IH04HM;^<)3"]&WFZDY>V^QWTT)F!9M7F1L?/I=6+ICRAT:$;<
M*"GM<+(=R+H%*Q=V*J@"A&2Z2U)MSNL+WYSIKJF*U0>];CBI/6M' 6@T =;1
M8B1=L(?MHP<C !*"ND-R36<JD);6T\#!#U!#>!LLHE IH18/NJSC>+?YQ054
MK0CXOB\]](#\ ,*Z@L,$ E1#'[\ %@GM"R3RZ,&=6,\.\ MAY*4$I41_XCI;
M\$O#,A&SA!#*KK,<B;8AJ,<W6$?QM9T_+WH;56&-C%^.W$<QNRM6[Y$]G]XB
MYM-Q %@/M0PP;MJHQX#\5":9YAO2J@M_([.4X8?1H9.RFJ'@/>53/P-.0E>;
M\AA",]^+KKJ)V[%0*J\JB<U3? G#FX$_#T$K8JV\V>,M(?0.9\>@70,9ZO6Z
M,OG>\UMNLV:7R^NN>E+4@]#E"?J2(U .R/(^SXYE._"@]V?@^R$[B2SI49=J
M;P@4!=B\K$/^5CJ."O7HZ""0S];&"8)_ZN<-0/0K#4\CGH+EJ,:';J"J82B(
MK J@K/);!MKVD0#I0 8J@$"ET+7GQ=@<"J1X]90LX$[@Z>J7:%VER BCWGK^
M-5# 0I,LB!P:6DV&-J=/7[#7%,_Z68H%#8) '@,:9E]O_CTB7V,187JEIDX<
MN,H@BU=_4WN2LZ0FA 0:4BX=Z!TO\LF*[PO:*[$1A0*.N$P:T08L#KB#2,N#
M1D"T0*0-J%G"97@?Q1FH;+*/)J+R08,"08L.I(U&T?^K7"BL%@H%DO"NR(6P
M%4$*@M['T8D:NQ@2:J2(G2,WL; )Y""#.ZCX9(HS2[EZ\5C"+T/1^L2&> !H
MD#\#:=$%@8,<E(7V/N2S%%>!+HTW<>;B@AF81FTC_UAXEL5^C(X,X-Q$R0)'
M\O>(OO^&<Z7>X=<=?T-DZ3>G*I7FJ4KS5*4_6?&H4UU%U]7IJW0\4O3K+OU#
MN($ZB2B&%X9"&,%%6OUJHK]C9NV53\Y#^C E#"LI:5?%.%!>VF 7-)K58&5Q
M 8]_<KN.U/SVS:&;36>H:+FN BAYS/[ <]5X)P-AID:AK'^%8_U>+65Q =04
MG&!=C8_0K;)]@9$UZ9",Q;L/A?3;M&HRVA-/&*7-L/=&V<BV>64R=^X+>E)?
MT'J^4'I1OJ!#@;8.:'[QC>G$1P BP,0ES_7FWV4U1\3&1MQTEU7[?0\4?)6T
MT)G0+Q96'IA$58QJ7&GC>D+SN:OIE1U5R@/%%9/ L9"1X"",+^#4D+9FGDQ0
M,C&"QO*NT&)<7###K+(RV,3?/ J*9:(,+C0OEDGV]_%BB:K(W@5-A_F>H\S(
M([IH(E:AETD$.P2[Q/'Z"HEZ"\ZTCL]C2XF&:W('3[L,'.354<DH3>%*V$2?
M,/LNQA"FH!@K8-*,+ O]762,G7(?K&U K,#PGHO#CD3;C]"!8)*&@&: %N;X
MJ)S&A&C_X3W0-@]JYY3D)CYQ)\*-EN1C$HP)Q6';"HE HG^CC0$4Q_-C4]06
M:#DKJ [%!8]NV:4+S?W .->P6RW6#$[WJZKQ)QB;N]X-7UQ(.BB3R40&E<<,
MS_ZT4\!-_ +X*@WKB(&<M>PS;LQ:TB .-QJO)J4B:B<"R_@07MMY_Z+E2LOX
M5U ,3.8"X^B9M-H8$,1OFRP75\B(7F6ZBAAVB+=3<3V=L^<+4(Q!+XTP[2'4
M/FW0?A<7@J@=D'4*'',KG!L<M[22ZP'077V-+<#$'@>W<&9[:<>>$4 Z)2!@
MMZI\.GHJ4"3PD&' $PQ9.8"-M;Q16&$PO\#+;<SFPT#YJXEWR5%(&4%,?YG"
M 5A1M2-O@6ZA_!S0!C>HUN!IQX4Z[0=])(2Q&C"FX63Y0->>N>MB]D*;<@NT
M2Q-3B4M;2FG6&7("&$4B/&@Y)-WP$U"N2D+TW CL"_24H(<D9 )S/!"HCNP
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M*CI#HTXJ!HEY7.7E4IE'W8'$Q'3Q;JIF:(H1/*F8+AI):N]8TK>B'@9R+!2
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MG\^^_#,XJ*QY-]MG%]V/M>9E_:TBQ_\'4$L#!!0    ( -R"6U5U/4:Z50,
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MJ58'^2'84MC7[1Y5L.Y\4PFTO5S-#'\#4$L#!!0    ( -R"6U664YSP_@H
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M=%5 < #6 #HJ-5K,9SYGDB7>S6,!:O*0E,^#]U "ZMW"TF.[S0P@#@B=;H<
M02((M:-\@C2G$>//K/&XPXQMQ0"XG[$87J'T1+F%:E 3VFAUA@0$V!"? &:M
MT _E,RF(R?=XB@J0K,$+<1=Q+ Y45OUSG5!R#+;?JG5+5X?=-E,684 DP>X
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MF;5[!O E2R<_;YSNLSY601FC))T^4RALRSL-PKA'&R&^ATHH8Y1<,V0.A?/
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MSS035 ?'E@,A%#+BG-=*:RB0KU.J9G90^ZCDTLPW:SM#L#T%H- 19[8&K>+
M7_U<1UZL?PN2KU"#WTZ B-UK$NNU&W'L)E(49W*1$.6A'M)#N:,NK/0;;9C\
MK9E3M7O]E <SLGE;:-)#?2EH+Z"DJU#3..?6G97\P5/KG@[*&S$QK3*&LV8J
MFW 6#[DDP>OR/1F4+V(66F$+!>][(AY5MC#Q^D[)F%+W^$1OCS9 0@2L -HE
MB/GILU#@W"Z0:>H6$\GX<3RWIO5M9O*WF=KX@C<-@N6@78.YB!-@'.DJ2/]<
MZ$63]^M[.J7*35-XH"OSWC;T&+XH A2']@_J&X7 &"JZZ:)[Y.O&;G#OJRV^
M<;_<.UGMEO\!4$L! A0#%     @ W();5<-#Y=@7+P  +D\!  H
M     ( !     &5X,3 M,2YH=&U02P$"% ,4    " #<@EM5< O[N:\)  !7
M-0  "0              @ $_+P  97@U+3$N:'1M4$L! A0#%     @ W();
M5<^E3C@Y"@  [2L   H              ( !%3D  &5X.3DM,2YH=&U02P$"
M% ,4    " #<@EM5YGH)XJ43  #C:0  "@              @ %V0P  97@Y
M.2TR+FAT;5!+ 0(4 Q0    ( -R"6U6HJ:9=R2$  "'H   +
M  "  4-7  !F;W)M."UK+FAT;5!+ 0(4 Q0    ( -R"6U5U/4:Z50,  -$,
M   1              "  35Y  !S=')M+3(P,C(Q,#(T+GAS9%!+ 0(4 Q0
M   ( -R"6U664YSP_@H  ("&   5              "  ;E\  !S=')M+3(P
M,C(Q,#(T7VQA8BYX;6Q02P$"% ,4    " #<@EM5[ )&)%P'  #E5P  %0
M            @ 'JAP  <W1R;2TR,#(R,3 R-%]P<F4N>&UL4$L%!@     (
-  @ W0$  'F/      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
